Spatio-temporal Dynamics of the Wnt/beta-catenin Signaling
Pathway: A Computational Systems Biology Approach by Mazemondet, Orianne (gnd: 1019146591)
Spatio-temporal Dynamics of the Wnt/β-catenin Signaling
Pathway: A Computational Systems Biology Approach
Dissertation
zur
Erlangung des akademischen Grades
Doktor-Ingenieur (Dr.-Ing.)
der Fakultät für Informatik und Elektrotechnik
der Universität Rostock
vorgelegt von
M.Sc. Orianne Mazemondet, geb. am 1981/11/02 in Brest (Fr)
aus Rostock
Rostock, 2011/05/06
Principal Advisor: Prof. Dr. rer. nat. habil. Adelinde M. Uhrmacher
University of Rostock, Germany
External Reviewers: Prof. Dr. med. Arndt Rolfs
University of Rostock, Germany
Prof. Dr. James R. Faeder
University of Pittsburg, USA
Date of Defense: 2011/07/01
Abstract
Human neural progenitor cells (hNPCs) are a new prospect for neuron replacement therapy
in the context of neurodegenerative diseases, e.g. Parkinson’s disease. ReNcell VM cells are
hNPCs cultured in vitro that allow to investigate and understand the mechanisms of neuron dif-
ferentiation, before clinical studies can be performed. The Wnt/β-catenin signaling pathway is
involved in ReNcell VM cell differentiation. A first step to understand its role in this biological
process is to investigate the spatio-temporal dynamics of its signaling proteins.
This dissertation employs the cyclic workflow of computational systems biology, deploy-
ing both wet- and dry-lab experiments, to investigate the spatio-temporal dynamics of Wnt/β-
catenin pathway in ReNcell VM cells. By means of cellular and molecular biology techniques,
quantitative kinetic analyses of the pathway’s signaling proteins are performed. These show
biphasic kinetics during the first three days of physiological differentiation.
A computational model of ReNcell VM cell population is developed to investigate in silico
the sources of the biphasic kinetics observed in vitro. The in silico experiments describe the im-
pact of the cell asynchrony w.r.t. the cell cycle on the protein dynamics and give insights about
the role of self-induced Wnt signaling in the cell population. A stochastic investigation reveals
discrepancies in the deterministic approximation and emphasizes the importance of stochastic
approaches for modeling biological systems. We propose additional wet-lab experiments in
order to validate the in silico predictions, and hence close the loop of computational systems
biology.
Computational systems biology, Wnt/β-catenin signaling pathway, ReNcell VM cells, Stochas-
tic modeling

Zusammenfassung
Humane neurale Progenitorzelle (hNPZs) bilden eine neue Perspektive für Neuronen-Ersatz-
therapien zur Behandlung neurogenerativer Krankheiten, wie z.B. Parkinson. ReNcell VM-
Zellen sind gezüchtete hNPZs, die es ermöglichen, als Grundlage für klinische Studien, die
Mechanismen der Neuronendifferenzierung zu untersuchen und zu verstehen. Es ist bekannt,
dass der Wnt/β-catenin Signalweg im Differenzierungsprozess von ReNcell VM-Zellen invol-
viert ist. Ein erster Schritt, um seine genaue Rolle in diesem Zusammenhang zu verstehen, ist
die Untersuchung der spatio-temporalen Dynamik seiner Signalproteine.
Diese Dissertation folgt dem zyklischen Arbeitsablauf der Systembiologie, um, basierend
auf sowohl Nasslabor- wie auch Computerexperimenten, die spatio-temporalen Dynamik der
Signalproteine des Wnt/β-catenin Signalwegs in ReNcell VM-Zellen zu studieren. Mit Hilfe
von zell- und molekularbiologischen Techniken werden quantitative Analysen der zentralen
Proteine des Signalwegs durchgeführt. Diese zeigen eine biphasische Kinetik während der ers-
ten drei Tage physiologischer Differenzierung.
Ein Computermodell wird entwickelt, um die Quellen der biphasischen Kinetik zu untersu-
chen. Experimente mit diesem Modell zeigen den Einfluss von Zellasynchronität hinsichtlich
des Zellzyklus auf die Proteindynamik. Sie geben desweiteren Einsicht in die Rolle autoindu-
zierter Wnt-Signale. Eine Untersuchung der stochastischen Eigenschaften des Modells zeigt
Diskrepanzen in der deterministischen Approximation auf und unterstreicht damit die Signifi-
kanz stochastischer Ansätze zur Modellierung biologischer Systeme. Vorschläge für weiterfüh-
rende Experimente zur Validierung der auf Basis des Modells getätigten Vorhersagen werden
unterbreitet. Dadurch wird der Kreis der Systembiologie, vom Labor zum Computer und zu-
rück, geschlossen.
Systembiologie, Wnt/β-catenin Signalweg, ReNcell VM Zellen, Stochastische modellierung
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Chapter 1
Introduction
Neurodegenerative diseases, such as Parkinson’s or Huntingon’s diseases, are characterized by
a large amount of dysfunctional or lost neural cells and neurons, especially dopaminergic neu-
rons. Among conceivable treatments, e.g. drug treatments, regenerative therapies that consist
in neuron transplantation into the patient brain, are a new hope. In this context human neural
progenitor cells (hNPCs) are a recent prospect to obtain the required amount of neurons and
dopaminergic neurons before transplantation. They are issued from different parts of the brain
and are defined by two properties: self-renewal (capability to remain undifferentiated and to
stay in proliferation) and multipotentiality (differentiation in different cell types restricted to
neural cell line). Nowadays, hNPCs can be isolated, cultured and expanded in vitro that allows,
before any clinical studies, the investigation of the mechanisms underlying their differentiation
and neurogenesis. Especially, understanding in a integrative manner the molecular aspects of
these cellular processes will increase our comprehension of such biological processes.
Signaling pathways are responsible for cellular adaptation toward environmental changes,
leading to physiological decisions such as cell death, differentiation, cell fate but also to onco-
genesis. Signaling molecules are present extracellularly, and constitute intermediates for cell-
cell communication: they are the means by which a cell can influence the behavior of neighbor
cells, i.e. paracrine signal, or its own behavior, i.e. autocrine signal. Signaling pathways are
triggered when signaling molecules bind to cell membrane receptors, followed by a cascade of
intracellular reactions, among which are protein phosphorylation and spatial relocation, medi-
ated by signaling proteins. Finally, a target protein transfers the signal into the nucleus where it
results in specific gene expression in order to adapt the cell behavior.
It is common that signaling proteins are shared components between pathways. This can lead
1
2to potential cross-talk that can be undesirable as it might result to inappropriate cell changes
[Albert and Oltvai, 2007]. A signal specificity is defined as follows: a given stimulus (signal),
activates one pathway leading to the desired cell response [Bardwell et al., 2007]. To ensure
specificity, mechanisms have evolved among which pathways mutual inhibition or activation,
but most importantly, spatial and temporal insulation [Takahashi et al., 2006,Kholodenko, 2006,
Albert and Oltvai, 2007].
Spatial insulation is achieved by compartmentalization, protein relocation, and the presence
of macromolecular complexes [Albert and Oltvai, 2007]. Temporal insulation is due to the
magnitude and duration of the signal, and of protein activation and phosphorylation [Sabbagh
et al., 2001]. It is reinforced by the presence of feedback loops, negative ones that downregulate
the pathway, and positive ones that amplify it [Kholodenko, 2000, Xiong and Ferrell, 2003,
Brandman and Meyer, 2008]. Furthermore, temporal insulation is also involved at the cell
level, as the response to a specific signal depends on the cell development stage.
Thus, to fully understand a pathway involvement in a cellular response, time-course analy-
sis and spatial resolution are needed. This underlines the importance of kinetic analyses when
studying signaling pathways. Nonetheless, due to the broad time scale involved in signaling
pathway, from phosphorylation (milliseconds), diffusion (seconds), to cell responses and gene
transcriptions (minutes, hours) [Tyson et al., 2001], [Alon, 2007, pg.6], kinetic analyses are
fund and time consuming, not to mention that they are limited by technical and manpower re-
sources.
Traditionally, molecular and cell biologists have a reductionist approach toward signaling
pathway study: Exploring through wet-lab experiments, a given set of proteins in an animal
or cell model, manipulated or not, e.g. mouse, in vitro cultured cells. Such approach can be
successful to identify proteins and their interactions, and the organizational and mechanistic
level of a pathway. However, observation of biological components in an isolated manner has
limits. On the one hand, it is rarely possible to observe biological elements independently due
to the intricate nature of living systems. On the other hand, it is the dynamic interactions be-
tween molecules that determine the function of a biological system [Wilkinson, 2009]. The
latter requires taking into account complex changes in time and space, that is beyond the tra-
ditional thinking of experimentalists and needs a more abstract conceptualization [Nurse, 2000].
A computational model is an abstract mathematical representation of a system under study,
that is then analyzed with help of computers, and by this way, helps to overcome the linearity
3of Human thinking [Doerner, 1980]. It offers a complementary approach to develop and test
hypotheses and make predictions regarding biological systems. Besides, when developing a
computational model, one can structure the knowledge and acquires a better understanding
about the system under study [Cellier, 1991].
Computational models of signaling pathways are dynamic models that depict the changes
over time of the system properties [Ellner and Guckenheimer, 2006]. Thus, not only they rep-
resent proteins and genes interactions but also analyze how these interactions change over time.
By this way, non linearity of the system, e.g. presence of feedback loops, and the temporal
insulation are easily analyzed with computer power and the specificity of the pathway can be
captured. Furthermore, integration of spatial aspects and element of insulation, e.g. compart-
ments, protein relocation, should, ideally, be included in dynamic models [Takahashi et al.,
2006, Kholodenko, 2006, Ahn et al., 2006].
Dynamic models are built based on experimental data and previous knowledge gathered
about the system under study. Protein interactions can be represented as biochemical reactions,
in a similar manner as biologists describe signaling pathways. Model analyses are multiple and
encompass computational simulation and mathematical analyses, and are selected depending
on the model characteristics.
Stochastic modeling, as described in [Gillespie, 1977], considers models in terms of mul-
tisets of molecules, representing chemical solutions, and chemical reactions rules. Molecular
interactions are regarded as discrete events randomly distributed in time. Analysis of stochastic
models in terms of stochastic simulation gives a picture of the component at a given time and
each simulation run represents a random experiment.
Deterministic modeling studies usually transform chemical reaction rules into ordinary dif-
ferential equations (ODEs) and regard concentrations instead of multisets of molecules. The
equivalent to simulation in the context of ODEs is numerical integration. Studies based on
ODEs form an approximation of the stochastic approach [Wilkinson, 2009]. They may neglect
significant differences in the behavior of systems with some chemical species in relatively low
abundance that arise from stochastic effects.
Although standards are lacking for model development [Klipp and Liebermeister, 2006], the
process is usually initiated based on prior knowledge in order to design the pathway structure,
the proteins involved and protein interactions. Besides, in order to depict the pathway dynamics,
values for the model parameters are needed, e.g. number of molecules (or concentration), and
rate constants. Ideally, these are measured directly in the system under study, as the closer ki-
netic parameters relate to experimental data the more reliable the results of a modeling study are.
4However, gathering all model parameters from biological experiments is one of the challenges
in the modeling task. The reasons are manifold: although techniques that can provide quantita-
tive biological data are increasing, they remain time-consuming and expensive to acquire, and
the obtained data can suffer from a lack of reliability [Schilling et al., 2005]. Thus, most of the
values needed for model parameters are usually lacking. This lack can be overcome by param-
eter estimation, that aims to find value for missing parameters such that the model output fits
the reference data, e.g. experimental data [Aldridge et al., 2006]. After the model is designed, a
series of analyses follow that aims to verify whether the behavior of the model species meet the
post hoc constraints [Aldridge et al., 2006]: the simulation data are compared to data provided
from experimental analysis, e.g. data issued from microscopy, cytometry, or immunoblotting
experiments. When the simulation data do no fit the experimental ones, the model structure
and the parameter values, especially the estimated ones, can be questioned. Sensitivity analysis
can then be used to determine which parameters have the most influence on the model behavior
and by this way, determine which ones can be changed [Aldridge et al., 2006]. These model
analysis are performed an iterative manner until satisfying results are found.
Computational systems biology defines the synergistic work between wet- and dry-labs, that
encompasses "‘experimentation and computational modeling"’ [Klipp et al., 2005, pg.14]. It is
considered as a field of biology that aims at studying biological systems with their dynamics,
interplays and interactions and by doing so provides an integrative view on these systems. The
workflow is performed as an iterative cycle, driven from prior knowledge issued from wet-labs,
biological questions and hypothesis are tested with computational modeling and subsequently
in-/validated with further wet-lab experiments [Kitano, 2002, Glass et al., 2006]. As already
mentioned, computational systems biology is strewn with bottlenecks, such as the lack of stan-
dards and of reliable quantitative data. Another challenge lies in the interdisciplinarity of the
field, as it involves expertise in various scientific fields among which are medicine, biology,
physics, mathematics and computer science. Thus, scientists involved in the field of computa-
tional systems biology must learn, and be willing to do so, the idioms from other disciplines.
1.1 ReNcell VM cells and Wnt/β-catenin signaling pathway
ReNcell VM cell line is a recently established hNPC line [Donato et al., 2007]. The cells
are issued from the ventral mesencephalon of a 10 weeks old fetus and are immortalized with
v-myc. It is established that ReNcell VM cells are able to differentiate into glial cells (astro-
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2010]. Furthermore, ReNcell VM cells present the advantages of a short doubling-time, i.e.
time needed for a population to double, and an easy and standardized cultivation protocol that
are essential for in vitro experimentation. The transition from proliferation to differentiation is
simply performed by removal of the growth factors from the cell environment. However, this
transition is not synchronous in the population due to the cell commitment to the cell cycle, i.e.
process that keep the cell in proliferation [Mazemondet et al., 2011].
Wnt/β-catenin signaling pathway, among two others, is triggered by Wnt molecules that are
released by the cells and are distributed along the cell field to coordinate changes in the whole
population. The Wnt/β-catenin signaling pathway is known to participate in the proliferation
and differentiation of NPCs [Castelo-Branco et al., 2003] and ReNcell VM cells [Schmöle
et al., 2010, Hübner et al., 2010, Mazemondet et al., 2011]. When binding to the receptors of
the Frizzled family and co-receptor Low-density lipoprotein receptor-related protein 6 (LRP6),
Wnts activate the first protein relocation: transfer of Dishevelled proteins (Dvl) from the cytosol
to the cell membrane. Consequently, the protein β-catenin that is no longer phosphorylated by
glycogen synthase kinase 3 beta (GSK3β), accumulates in the cytosol and shuttles into the
nucleus. In the latter, β-catenin becomes a transcription factor leading to the transcription of
specific genes such as AXIN2.
ReNcell VM cells are known to be receptive to Wnt/β-catenin pathway activation or inhibi-
tion during proliferation and differentiation of ReNcell VM cells: inhibition of GSK3β leads,
to the pathway activation and to an increase of neuronal cells [Schmöle et al., 2010], and ac-
tivation of the pathway during proliferation increases the transcription of target genes [Hübner
et al., 2010]. However, no investigation of the pathway in a physiological context, without pro-
tein overexpression or addition, has been performed so far. Thus, establishing a kinetic profile
of the intracellular signaling proteins’ dynamics in their subcellular location is a first step to
understand the Wnt/β-catenin pathway involvement in the ReNcell VM cell differentiation.
1.2 Contributions
In this dissertation we investigate the dynamics of the Wnt/β-catenin signaling pathway during
differentiation of ReNcell VM cells.
The work presented shows a duality between wet- and dry-lab experiments in order to un-
derstand the dynamics of signaling proteins, especially β-catenin. Within the field of computa-
6tional systems biology this dissertation illustrates a representative case of the cyclic workflow
starting with in vitro time-course and quantitative analyses of the pathway intracellular protein
expressions. In a second step, the data obtained are used to generate hypotheses regarding the
dynamics of nuclear β-catenin during the first 12 hours of ReNcell VM cell differentiation. Fur-
thermore, the obtained data provide a source of information for model evaluation and in silico
result comparison. A computational model of the pathway in ReNcell VM cell population is
created, driven by the previous in vitro results. It aims at testing hypotheses that arise from the
in vitro experiments. The model built is stochastic in order to investigate the potential effects
engendered by the low amount of one of the pathway components (Axin). By simulation anal-
yses one of these hypotheses is privileged as it predicts a β-catenin behavior similar to the one
observed experimentally. Thus we propose further in vitro experiments in ReNcell VM cells to
validate our predictions and by this way we close the loop of the computational systems biology
workflow.
1.2.1 Quantitative kinetics of Wnt/β-catenin pathway signaling proteins
Our results show that the Wnt/β-catenin signaling pathway is involved during different phases
of ReNcell VM cell differentiation. The internal signaling machinery is present in the cells
and presents spatio-temporal dynamics along the differentiation. A first increase of nuclear β-
catenin during the early hours suggests that the pathway is active as soon as differentiation is
triggered, whereas a second and later increase indicates the pathway involvement in the cell fate
commitment. We show that the pathway can be active during proliferation, under exogenous
stimulation with Wnt3a, however, the accumulation of β-catenin does not involve the same
mechanisms as during differentiation. Finally, we propose the ReNcell VM cells as a good cell
model to study specific signaling proteins, i.e. the co-receptor LRP6 and Dvl2, under Wnt/β-
catenin pathway activation, and to investigate the role of the pathway in hNPC differentiation.
By means of wet-lab experiments, such as cell culture, cell fractionation and immunoblot-
ting, we quantify the relative amount, i.e. fold change, over time, of the main signaling proteins
involved in the Wnt/β-catenin pathway: the co-receptor LRP6, the first intracellular protein
activated Dvl2, GSK3β, and the target protein β-catenin. The focus is on the first three days
of ReNcell VM cell differentiation, with a distinction between the early differentiation, from
0 to 8 hours, and the late differentiation, from 12 to 72 hours. The boundary between the two
phases is due to the cell fate commitment, as after 12 hours one can distinguish within the cell
population, a neuron from a glial cell. Proteins are quantified in their specific subcellular lo-
7cation, i.e. membrane, cytosol, and nuclear fractions. Two sets of experiments are performed
that comprise protein quantification under physiological differentiation, i.e. removal of growth
factors without addition of exogenous Wnt proteins, and under differentiation in presence of
exogenous Wnt3a that is known to trigger the Wnt/β-catenin pathway.
The kinetic analyses during physiological differentiation show that signaling proteins are
differently regulated depending on their location and over time. The protein dynamics present
biphasic kinetics: a first regulation wave during the first three hours of differentiation and a
second one after 24 hours of differentiation. The two regulation waves are separated by a phase
where protein levels are equivalent to the ones during proliferation. The first wave of regulation
is accelerated with the presence of exogenous Wnt3a, showing that the Wnt/β-catenin pathway
is active when ReNcell VM cells start to differentiate.
We show for the first time in hNPCs the phosphorylation-dependent Dvl2 mobility shift
[Bryja et al., 2007b] due to Wnt3a stimulation and we found that it happens only in the cytosol.
Interestingly the effects of Wnt3a on protein expression are different between proliferation and
differentiation. This finding supports the theory that Wnt molecules act differently depending
on the developmental phase of cells or tissues. It emphasizes the motivation to analyze the
pathway characteristics in each cell type and at different moments of the cell development.
1.2.2 Computational model of the Wnt/β-catenin pathway in ReNcell VM
cells
We propose two hypotheses to explain the two waves of protein regulation. The first hypothesis
concerns the asynchrony of the ReNcell VM cells toward the cell cycle during the proliferation
phase [Mazemondet et al., 2011]. Indeed only 53% of the ReNcell VM cells are able to differ-
entiate right after growth factor removal. The second wave of regulation could arise from the
pathway activation in the cells that differentiate after some delay due to their cell cycle com-
mitment. The second hypothesis is correlated to the nature of Wnt molecules: these signaling
molecules are produced and secreted by cells, and move toward the neighbor cells to propa-
gate the signal. Thus, the second wave of regulation could result from cell-cell communication
occurring after some delay needed for the Wnt production and secretion. Our hypothesis fa-
vors a continuous and self-induced Wnt signal between ReNcell VM cells. Testing these two
hypotheses in vitro has not been yet possible, thus we test them with in silico experiments.
Based on computational modeling, we investigate the origin of nuclear β-catenin dynamics
8observed in previous in vitro experiments, and show that the impact of the cell cycle asyn-
chrony is negligible when analyzing protein dynamics during ReNcell VM cell differentiation.
Our results further suggest that at the same time continuous and autocrine Wnt signal has con-
siderable impact. We also report on significant stochastic effects that directly result from model
parameters provided in literature and that are not observable in deterministic investigations.
We provide a model of the intracellular Wnt/β-catenin pathway that is derived from the ref-
erence model in literature [Lee et al., 2003]. Each ReNcell VM cell is represented with two
compartments, the cytosol and the nucleus, in order to compare the in silico protein dynam-
ics to the in vitro ones and to analyze specifically nuclear β-catenin dynamics. The model
represents the pathway with the three main proteins Wnt, Axin, and β-catenin, and includes
the negative feedback loop generated by Axin production. The model is expressed in terms of
chemical reactions, such that we can easily switch between the deterministic and the stochastic
realm only by parameter conversion. The model parameters are derived from a combination
of literature data [Lee et al., 2003, Krieghoff et al., 2005, Schmöle et al., 2010, Mazemondet
et al., 2011], wet-lab experiments, and parameter estimation. The model evaluation is based on
a deterministic investigation: a first increase of nuclear β-catenin is reproduced that fits the β-
catenin behavior proposed in the reference model [Lee et al., 2003], as well as the first increase
observed in vitro (from 0 to 2 hours). However, since our previous Western-blot data reflect
β-catenin amount in ReNcell VM cell populations and our intracellular Wnt pathway model
does not reflect the impact of the cell cycle, at this point it is implicitly assumed that ReN-
cell VM cells are synchronized regarding the cell cycle. In order to provide a more complete
characterization of the model, results of a sensitivity analysis are presented.
Stochastic investigation of the intracellular Wnt pathway model is performed. The motiva-
tion held in the reference model [Lee et al., 2003] as it appeared, in their biological system
(Xenopus oocyte) that Axin protein is in very low amount compared to the other pathway com-
ponents, possibly leading to significant stochastic deviations. Indeed stochastic simulation of
the model results in high fluctuations of the nuclear β-catenin level. In order to reduce these
fluctuations, two strategies are carry on by adapting parameter values while keeping low Axin
amount. However, both strategies failed and therefore a new parameter set is used with a higher
Axin amount. From this stochastic investigation, two hypotheses are directly derived: either
Axin amount in ReNcell VM cells is higher than suggested by [Lee et al., 2003], despite the
fact that in vitro detection of Axin in ReNcell VM cells did not succeed, or the intracellular Wnt
pathway model, and thus, our understanding of the system misses an important mechanism
to reduce stochastic noise, like dimerization [Bundschuh, 2003, Morishita, 2004] or additional
9feedback loops [Orrell et al., 2006].
To investigate the impact of the cell cycle, the intracellular Wnt pathway model is extended to
represent ReNcell VM cell populations and their heterogeneity toward the cell cycle. The main
assumption is that each cell has to complete the cell cycle before it can process the Wnt signal.
The ReNcell VM cell distribution over the cell cycle and the duration of each cell cycle phase
are obtained by wet-lab experiments and from literature [Mazemondet et al., 2011, Schmöle
et al., 2010, Alam et al., 2004], respectively. The results of simulating heterogeneous cell pop-
ulations show a lower amplitude in the first increase of nuclear β-catenin than observed in the
experimental data. This implies that our initial assumption of considering only homogeneous
cell populations to model the Wnt/β-catenin pathway is not feasible. More generally it means
that when modeling the Wnt/β-catenin pathway in ReNcell VM cells the cells’ commitment to
the cell cycle should be considered. We present an additional parameter set to fit the first in-
crease of nuclear β-catenin in our experimental data with the simulation data in heterogeneous
cell populations. The results imply that in wet-lab experiments on the Wnt/β-catenin pathway
in ReNcell VM cells, the impact of the cell cycle onto the β-catenin dynamics can be neglected.
In other words, the observations of Wnt pathway in ReNcell VM cells are not biased by the cell
cycle asynchrony.
We further extend our model with the process of self-induced Wnt signal, in order to propose
a source of induction for the second increase of nuclear β-catenin observed in vitro. A reaction
is introduced that models Wnt production and secretion by ReNcell VM cells. This reaction
starts when cells exit the cell cycle, but consumes a certain amount of time accounting for gene
expression and relocation processes that are presumably involved. Both continuous and discrete
Wnt secretion are tested. The simulation results suggest that with a Wnt production process that
is as fast as 2.5 hours, continuous and autocrine Wnt signaling may be an explanation for the
observed behavior of nuclear β-catenin in ReNcell VM cells, as simulation results fit well the
experimental ones. However, due to the standard error of the mean of some experimental data,
a discrete secretion can not be excluded and will need to be further investigated, eventually by
means of wet-lab experiments.
1.3 Outline
The thesis is structured in three main chapters. Chapter 2 introduces background regarding
the Wnt/β-catenin signaling pathway as well as hNPCs and ReNcell VM cells. In Chapter 3
spatio-temporal profiles of the pathway signaling proteins are presented during physiological
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differentiation and differentiation with Wnt3a stimulation, in Sections 3.2 and 3.3, respectively.
Chapter 4 includes computational model of ReNcell VM cell populations, in Section 4.2 and in
silico experiments regarding β-catenin dynamics, in Section 4.5.
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Chapter 2
Biological background
2.1 Wnt signaling pathway
2.1.1 Wnt proteins
Wnt proteins form a family of 19 glycoproteins with a conserved pattern of 23-24 cysteine
residues. The name Wnt comes from the Drosophila wingless (Wg) gene and the vertebrate
int-1 oncogene. Wnt proteins are highly conserved across species, especially within verte-
brates [Sidow, 1992]. They are secreted signaling molecules that regulate cell decisions such as
apoptosis, proliferation, differentiation, and polarity, but that are also involved in diseases such
as diabetes and cancers [Fuerer et al., 2008].
The synthesis and secretion of Wnt proteins remain unclear processes. After synthesis, Wnt
proteins undergo post-translational modifications in the endoplasmic reticulum (ER) with the
influence of other proteins, e.g. Porcupine (Figure 2.1). It is also in the ER that Wnt proteins
can bind chaperone proteins that help their sorting and later secretion. The intracellular traffic
continues from the ER to the Golgi network and to diverse subcellular compartments before
Wnt proteins are ready for secretion. The picture of Wnt secretion is incomplete, with diverse
proposed mechanisms that are yet a matter of conjecture. For recent reviews see [Coudreuse
and Korswagen, 2007, Hausmann et al., 2007].
When secreted, Wnt proteins act as morphogens and can impose a specific change in a cell
field in both short-range, i.e. to nearest neighbor cells, and long-range signaling, i.e. to cells
up to 20 cell diameters away [Zecca et al., 1996]. The latter produces a morphogen gradient
from the source, i.e. the cell expressing Wnt proteins, to the receiver, i.e. the cell responding to
Wnt proteins. This is defined as a paracrine signaling. Wnt proteins can also signal to the cell
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Figure 2.1: Wnt intra- and extra-cellular traffic. Adapted from [Coudreuse and Korswagen, 2007]. After their
synthesis Wnt proteins undergo maturation and post-translational modifications through the endoplasmic reticulum
(ER) and the Golgi network before secretion in the extracellular environment where Wnts bind to lipoproteins and
move along the cell field.
that produced them. This specific signaling is called autocrine. Thus morphogens in general,
and Wnt proteins in particular, are used by cells to establish communication between them, a
process referred to as cell-cell communication [van den Heuvel et al., 1989]. This process is
well known in Drosophila wing disc development [Strigini and Cohen, 2000] although how
Wnt proteins are transported in the extracellular space is yet hard to answer. This is partly due
to the fact that Wnt proteins are traveling close to the extracellular matrix and are thus difficult
to purify [The and Perrimon, 2000]. Nevertheless, it is known that Wnt protein transport is a
fast process around 50 µm in 30 minutes during the Drosophila wing disc development [The
and Perrimon, 2000]. The cell response to morphogen reception is a downstream process of
protein activation and gene transcription that define the term signaling pathway.
2.1.2 Wnt/β-catenin pathway
Wnt proteins target different signaling pathways that are distinguished depending on the protein
β-catenin activation. The calcium-dependent pathway and the planar-cell-polarity pathway do
not involve β-catenin, in contrast to the Wnt/β-catenin pathway, also called canonical Wnt
pathway, which is the most known and studied one.
The Wnt/β-catenin pathway mechanism is the following: In absence of Wnt proteins, cytoso-
lic β-catenin is phosphorylated by a multi-protein complex. This complex, called degradation
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Figure 2.2: Overview of the Wnt/β-catenin signaling pathway. (A) In absence of Wnt proteins, the degradation
complex phosphorylates β-catenin which is subsequently degraded by the proteasome. (B) In presence of Wnt
proteins, the receptor complex Fz-LRP6 is formed, leading to Dvl recruitment at the plasma membrane, followed
by Axin, GSK3β and CKI, resulting in LRP6 phosphorylation. As the degradation complex is dismissed β-
catenin can accumulate in the cytosol and further transfers to the nucleus, where it binds TCF and activates Wnt
responsive genes. Source [MacDonald et al., 2009].
complex, is constituted of four proteins called adenomatous polyposis coli (APC), Axin, casein
kinase I alpha (CKIα), and glycogen synthase kinase 3 beta (GSK3β) (Figure 2.2A). APC is
the scaffold protein of the degradation complex (Figure 2.2A), Axin is the binding element, as
it contains binding sites for all the complex components as well as a binding site for β-catenin.
Axin refers equally to the proteins Axin1 and Axin2 as both participate to the degradation
complex. GSK3β is a multifunctional kinase, involved in numerous pathways, which is active
when phosphorylated on the T-loop, on tyrosine 279 residue and inactive when phosphorylated
on the serine 9 residue [Doble and Woodgett, 2003]. Inactivation of GSK3β through phos-
phorylation on serine 9 is not observed during Wnt signaling transduction [Ding et al., 2000].
When GSK3β is active its substrate β-catenin has access to the catalytic site, only if a pre-
phosphorylation on the substrate serine residue is done beforehand [Meijer et al., 2004]. For
β-catenin, this pre-phosphorylation is done by CKIα. Thus β-catenin phosphorylation is a hi-
erarchical process starting with CKIα phosphorylation on β-catenin serine 45 residue, followed
by GSK3β phosphorylation on threonine 41 and serine 33 and 37 residues [Doble and Wood-
gett, 2003]. Phosphorylated β-catenin is tagged for ubiquitination and subsequent degradation
by the proteasome (Figure 2.3).
When Wnt proteins are present in the cell environment (Figure 2.2B), they bind to one of the
10 isoforms of Frizzled receptors (Fz) and their co-receptors. The specific combination of Fz
isoforms and co-receptors makes the specificity of the Wnt signal. For the Wnt/β-catenin path-
way, the co-receptor is the low-density lipoprotein receptor-related protein 6 (LRP6). Activated
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Figure 2.3: Schema of β-catenin phosphorylation and degradation cascade. Adapted from [Amit et al., 2002].
(a) Axin bound to β-catenin recruits CK1 to phosphorylate β-catenin on serine 45. (b,c) subsequently to the first
phosphorylation, GSK3β proceeds to phosphorylate in series until serine 33. (d) phosphorylation on serine 33/37
allows β-catenin ubiquitination by β-TrCp/E3RS, leading to β-catenin degradation.
Fz recruits LRP6, resulting in the signal transduction from the membrane into the cytosol. The
mechanisms underlying this step remain unclear. Dishevelled (Dvl) is the first cytosolic pro-
tein family to be activated (phosphorylated) and to be recruited from the cytosol to the plasma
membrane where it binds to Fz receptors. The Dvl family includes three proteins, Dvl1, Dvl2,
and Dvl3. Dvl2 isoform is the most abundant in mammalian cells [Lee et al., 2008]. Although
their respective roles in the activation of the pathway are not well understood, Dvl proteins are
thought to play a role at the crossroad for the activation of the different Wnt signaling path-
ways [Boutros and Mlodzik, 1999]. The complex Dvl-Fz is thought to form a scaffold for
Axin [Roberts et al., 2007], thus promoting its recruitment to the plasma membrane and leading
to the degradation complex disassembly. At the plasma membrane, Axin binds to LRP6 cyto-
plasmic tail and generates phosphorylations of the co-receptor, especially on the serine 1460
residue [Tamai et al., 2004].
After deactivation of the degradation complex, non-phosphorylated β-catenin accumulates
in the cytosol and shuttles into the nucleus. The β-catenin accumulation in both compartments
is the hallmark of the pathway activation. The process governing β-catenin shuttling between
cytosol and nucleus is assumed to be a facilitated diffusion combined with compartment re-
tention as no shuttling partners have been found so far [Krieghoff et al., 2005]. Once in the
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nucleus, β-catenin binds to the transcription factor T-cell factor (TCF) leading to Wnt specific
gene transcription. Currently 107 genes are known to be regulated following Wnt signaling
(details and updates at the Wnt homepage http://wnt.stanford.edu). Among these target genes,
AXIN2 over-expression is the indisputable sign of Wnt/β-catenin pathway activation [Leung
et al., 2002]. Furthermore, as the protein Axin2 regulates negatively the pathway by partic-
ipating to the degradation complex, AXIN2 transcription is a negative feedback loop of the
Wnt/β-catenin pathway [Leung et al., 2002].
A classification of the 19 Wnt proteins has defined Wnt1, Wnt2, Wnt3a, Wnt7a/b and
Wnt8a/b as triggers of Wnt/β-catenin pathway [Lange et al., 2006]. However, the last years
of research have changed the Wnt pathways’ paradigm. It has been shown that a given Wnt
protein does not always trigger the same pathway. The current consensus is that more than
the Wnt protein itself, it is the cell type and the receptors present at the cell membrane that
determine the pathway to be activated [Mikels and Nusse, 2006]. Thus classification of each
Wnt protein regarding their respective effects in different cell types and organisms remains an
ongoing task. The investigation of the Wnt pathways started 27 years ago, and still some mech-
anisms of the signaling cascade remain unclear. How Wnt leads to LRP6 activation, and inhibits
β-catenin phosphorylation [Tamai et al., 2004,He et al., 2004] ? How does the signal transduce
from its receptors Fz and LRP6 at the plasma membrane, to the destruction complex in the
cytosol ? How does β-catenin transfer from the cytosol to the nucleus ? Exploration of Wnt
proteins and Wnt/β-catenin pathway downstream and upstream of the signal reception are still
needed to answer the remaining questions.
2.2 Human neural progenitor cells
2.2.1 ReNcell VM cell line
Human neural progenitor cells (hNPCs) are a new hope in cell replacement therapies for neu-
rodegenerative diseases, e.g. Parkinson’s and Huntington’s diseases [Lindvall and Bjoerklund,
2004]. These diseases are characterized by a loss of neural cells, i.e. neurons, and more specif-
ically dopaminergic neurons. These dopaminergic neurons are located, among several areas,
in a region of the central nervous system (CNS), i.e. the brain, called mesencephalon or mid-
brain [Smidt and Burbach, 2007] and are issued from neural progenitor cell differentiation.
Progenitor cells, like stem cells, have the ability to maintain their proliferation state, i.e. their
self-renewal. However, unlike stem cells, they are niche specific and mature in diverse cell types
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specifically of their original tissue. Thus, progenitor cells issued from the CNS are committed
to given cell fate, neural cells, i.e. neurons and glial cells [Hirabayashi and Gotoh, 2010].
The ventral mesencephalon (VM) contains a neurogenic niche, thus cells issued from this
region are suitable for in vitro studies of neural progenitor cell differentiation and neurogenesis.
ReNcell VM is an immortalized cell line derived from the ventral mesencephalon, of a ten
week old human embryo. The cell line is immortalized by retroviral transduction with the v-
myc oncogene. Immortalization is needed to maintain cell viability as well as stable genotype
and phenotype when cultivated in vitro [Donato et al., 2007]. The ReNcell VM cells remain
in a proliferative state in the presence of growth factors such as basic fibroblast and epidermal
growth factors (bFGF, EGF). After removal of the growth factors from the media, ReNcell
VM cells are able to differentiate into neural cells [Donato et al., 2007], especially dopaminergic
neurons [Morgan et al., 2009]. So far ReNcell VM cells remain a research cell line only and
application for human therapy is not its purpose. Thus investigations of ReNcell VM cells are a
first means to explore and understand the molecular mechanisms underlying hNPC proliferation
and differentiation.
2.2.2 Cell cycle in ReNcell VM cell line
The cell cycle is the biological process leading to DNA duplication and cell division into two
identical daughter cells. This process allows a cell population to stay in the proliferation state
and to exponentially grow. The cell cycle is usually described as a succession of four different
sequential phases (Figure 2.4):
1. The G1 phase (gap 1) is the cell growth phase, throughout which the cell undergoes mor-
phological changes. During G1, a cell can also enter in a resting phase, called G0. While
in G0 the cell remains quiescent for a long time, which can possibly be indefinitely, before
coming back to G1 if it receives the appropriated signals. At the end of G1, a restriction
point (R) will decide whether the cell remains commited to the cycle and will proceed to
DNA replication and division or has to leave the cycle and starts its differentiation.
2. The S phase (synthesis) consists in the DNA replication.
3. The G2 phase (gap 2) stands between S and M phases and allows the cell to continue
its growth. In the meantime the previous replicated DNA will be checked and a second
restriction point will decide for the continuation of the cycle.
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Figure 2.4: Typical cell cycle showing the four phases and their relative duration in mammalian cells. Mod-
ified from [Alam et al., 2004].
4. The M phase (mitosis) is the real division phase. The nucleus and its content, i.e. the
chromosomes, divide equally in two, followed by the cytoplasm equal division. The M
phase leads to the generation of two identical daughter cells.
On average, in mammalian cells, the cell cycle has a duration of 24 hours, with the following
distribution: G1 phase lasts for 12 hours, S for 8 hours, G2 between 2 to 4 hours and about 1
hour for the M phase [Alam et al., 2004] (Figure 2.4).
The cell cycle is critical for the cell survival, and thus it is protected by intra- and extracellular
signals. Intracellular signals are governed by family of proteins called cyclin-dependent kinases
(Cdks) and through their binding to other proteins, known as cyclins. Extracellular signals are
triggered by the presence of growth factors or mitogens, e.g. nerve or epidermal growth factors
(NGF, EGF), in the cell environment. Their presence promotes cell growth and cell division
through the cell cycle. To illustrate, an absence of external growth factor, will inhibit a cyclin-
Cdk complex leading to the arrest of the cycle at the G1 restriction point. Thus the passage
from G1 phase to S phase is feasible only in a favorable environment, i.e. in presence of growth
factors. However this does not apply to the checkpoint in G2. If an error is detected during the
cycle, the only alternative is death, i.e. apoptosis. Indeed a cell already commited into S, G2
or M phases can not leave the cell cycle until the division is finished. In this case, the cell will
interpret the lack of growth factors only after ending the cycle, when re-entering G1 phase. The
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Figure 2.5: Cell cycle analyses during differentiation of ReNcell VM cells. Source [Mazemondet et al., 2011].
passage from one phase to another has been intensively studied and the probabilities for a cell
to go through the checkpoints is thought, especially for G1 checkpoint, to follow an exponential
distribution [Smith and Martin, 1973].
The cell cycle of ReNcell VM cells has a doubling time, i.e. the duration of one cycle, of
around 19 hours and 40 minutes [Schmöle et al., 2010]. However, the cells are asynchronous
in the cell cycle (Figure 2.5), i.e. the whole cell population is not encompassed in one phase
but distributed all over the cell cycle. Indeed, the distribution of the ReNcell VM cells in the
cell cycle is the following: about 53% of cells are in G0/G1 phase, 23% in S phase and 20%
in G2 phase (Figure 2.5). Thus, when the growth factors are withdrawn from the media, only
53% of the cells will be able to start the differentiation and it will take up to 24 hours before all
the cells leave the cell cycle and enter the differentiation process. Therefore, this asynchronism
of the cell population should be taken into account during the study of molecular mechanisms
underlying cell differentiation.
2.2.3 Wnt/β-catenin pathway and neural progenitor cells
Wnt signaling pathways are involved in proliferation, differentiation and cell fate processes in
diverse neural progenitor and stem cell lines, although a consensus regarding their real functions
has not been reached. It has been first established that Wnt/β-catenin pathway accompanies pro-
liferation of neural stem cell derived from the CNS [Castelo-Branco et al., 2003,Zechner et al.,
2003,Michaelidis and Lie, 2008]. However, evidence accumulates that the Wnt/β-catenin path-
way is equally involved in the differentiation process: Cortical neural precursors are able to dif-
ferentiate into neurons under the pathway stimulation in presence [Hirabayashi et al., 2004] or
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absence [Israsena et al., 2004] of growth factors. Lately, the implication of Wnt/β-catenin path-
way to promote neurogenesis and to inhibit gliogenesis, has been demonstrated in the neuro-
sphere of neonatal forebrain in mouse [Kunke et al., 2009]. Furthermore, evidence arose that
β-catenin is specifically involved in differentiation and dopaminergic neurogenesis [Castelo-
Branco et al., 2004, Lange et al., 2006, Tang et al., 2009].
In ReNcell VM cells inhibition of GSK3β is leading to an accumulation of nuclear β-
catenin and an increase of neurogenesis [Schmöle et al., 2010, Lange et al., 2011], suggesting
that the Wnt/β-catenin is active in ReNcell VM cells and involved in neuron differentiation.
However, the duration and the nature (autocrine or paracrine) of this signal remain unclear. Au-
tocrine Wnt/β-catenin signaling is known to occur in neural stem cell [Wexler et al., 2009] and
brain development [Chenn and Walsh, 2002, Canning et al., 2007], respectively, but has not yet
been investigated for ReNcell VM cells, in particular. It is noteworthy that ReNcell VM cell
immortalization with v-myc might have some drawbacks on Wnt/β-catenin pathway analyses
as in many cell lines myc is a downstream target of the Wnt signals [Sansom et al., 2007].
Whether this is also the case in ReNcell VM cells needs future investigation.
Thus, different and opposite effects, i.e. proliferation and differentiation, of a given Wnt pro-
tein or the Wnt/β-catenin pathway, are observed in neural progenitor and stem cell population,
also depending of the stage of the CNS development. This disparity suggests that each Wnt
protein has his own profile of action, in a given cell line, in relation with the cell development
stage [Michaelidis and Lie, 2008].
2.2.4 Wnt3a and neural progenitor cells
Although a given Wnt protein does not always trigger the same Wnt pathway, depending on
the cell type and cell state, Wnt3a is commonly refered as a trigger for Wnt/β-catenin pathway.
This is accepted since cells expressing Wnt3a have demonstrated an elevation of β-catenin level
in the cytosol [Shimizu et al., 1997]. Later, Wnt3a appeared to be a ligand for the co-receptor
LRP6 [Liu et al., 2003] and to phosphorylate LRP6 on its serine 1490 residue [Pan et al., 2008].
It is thought that Wnt3a signaling leads to the recruitment of Axin to LRP6, inhibiting Axin
binding to β-catenin, that results in β-catenin accumulation [Yamamoto et al., 2006].
Investigation of Wnt3a impact on neural cell development established that Wnt3a is involved
in the proliferation of neural progenitor cells in rat ventral midbrain [Castelo-Branco et al.,
2003]. It further mediates the self-renewal of mouse neural progenitor cells [Kalania et al.,
2008] and neural progenitors derived from human embryonic stem cells [Davidson et al., 2007].
Controversially, it has been shown to promote neuronal differentiation in neural stem cell culture
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[Muroyama et al., 2004].
ReNcell VM cells transfected with Wnt3a vector present an increase of TCF activity and of
Wnt/β-catenin pathway specific gene transcription, i.e. AXIN2, Cyclin D1, during proliferation
[Hübner et al., 2010]. Furthermore, these transfected cells tend to differentiation into neurons
rather than glial cells, suggesting a role of Wnt3a in the cell fate.
Chapter 3
in vitro exploration
This chapter presents the in vitro exploration of the Wnt/β-catenin pathway in ReNcell VM cells
using molecular and cellular biology techniques. Details about the methods and the procedures
applied for wet-lab experiments are explained in Section 3.1. Description of in vitro results are
given in Sections 3.2 and 3.3. First, the spatio-temporal profiles of the Wnt/β-catenin path-
way components during the first 72 hours of ReNcell VM cell physiological differentiation are
detailed (Section 3.2). Second, the component profiles in presence of exogenous Wnt3a are
reported during proliferation and differentiation of ReNcell VM cells (Section 3.3). These ex-
perimental results are discussed, interpreted and hypotheses regarding the protein regulation
during ReNcell VM cell differentiation are proposed in Section 3.4.
3.1 Material & Methods
The following section describes molecular and cellular biology procedures carried out during
wet-lab experiments to explore in vitro the spatio-temporal dynamics of intracellular protein
within ReNcell VM cells. It documents the specialized material and experimental techniques
used and aims to allow other researchers to replicate the work done if needed.
3.1.1 Solutions & Material lists
Cell culture buffers
Differentiation medium
DMEM:F12 1:1 w/o L-Glutamin 482 mL Gibco #21331-020
B27 supplement 10 mL Gibco #17504-044
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GlutaMax I 2 nM Gibco #35050-038
Heparin sodium salt 10 U/mL Sigma #H 3149
Gentamycin 50 µg/mL Gibco #15750-037
Proliferation medium
Differentiation medium
Epidermal Growth Factor 20 ng/mL PeproTech #100-15
Basic Fibroblast Growth Factor 10 ng/mL Roche #11120417001
Trypsine/Benzonase
Trypsin-EDTA (1x in HBSS) 100 mL Gibco #25300-054
Benzonase 250 U/µL 10 µL Merck #1.01654.0001
Trituration solution (Trit)
Soybean trypsin inhibitor 50 mg Sigma #T-6522
DMEM:F12 1:1 w/o L-Glutamin 87.4 mL Gibco #21331-020
Human serum albumin 4.5 mL Octa Pharma #10542a/96
Benzonase 9.1 µL Merck #1.01654.0001
Cell culture products & equipments
Mouse Laminin 1 Protein 1 mg/mL Trevigen #3400-010-01
Recombinant mouse Wnt3a
reconstituted 40 µg/mL in sterile PBS R&D Systems #1324-WN
PBS w/o Ca2+ and Mg2+ Biochrom AG #L 1825
HBSS w/o Ca2+ and Mg2+ Gibco #14170-088
Phosphostop Roche #04 906 837 001
Cell counter CASY®, Innovatis AG
Microscope Biozero, Keyence
ReNcell VM cells ReNeuron, Milipore
Qproteome Cell Compartment Qiagen #37502
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Western-blot buffers
The chemicals’ suppliers are the companies Calbiochem, Fluka, Merck, Sigma and Roth.
TBS (pH 7.5) TBST (pH 7.6)
NaCl 150 mM TBS 100 mL
Tris-Hcl 7.7 mM Tween 20 1%
Distilled water 1 L Distilled water 900 mL
Transfer buffer (pH 8.3) Electrophoresis buffer (10 fold)
TRIS 6.06 g TRIS 3.03 g
Glycine 28.02 g Glycine 14.1 g
Methanol 400 mL SDS 10 g
Distilled water 1.6 L Distilled water 1 L
Laemmli buffer (5 fold ) Colloidal Coomassie Dye (CCD)
SDS 1.5 g Coomassie Brillant
Tris-Hcl 1 M Blue 5% in Distilled water 10 mL
Bromphenol blue 10% Phosphoric acid 6 mL
DTT 1.16 g Ammonium sulfate 50 g
Glycerin 87% Distilled water 490 mL
Distilled water 15 mL
Colloidal Coomassie Solution 1°Antibody buffer
CCD 200 mL Albumin Serum in TBST 5%
Methanol 50 mL
Blocking solution I 2°Antibody buffer I
Skim milk powder in TBS 5% Albumin Serum in TBST 5%
Blocking solution II 2°Antibody buffer II
Albumin Serum in TBS 5% Skim milk powder in TBST 5%
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Western blot products & equipments
Prestained peqGOLD marker IV PEQLAB #27-2111
Nitrocellulose membrane, Amersham Hybond-ECL GE Healthcare #RPN303D
CriterionTM Precast Gels 4-15% Tris-HCl, 1.0 mm
12+2 Well Comb, 45 µL BIO-RAD #345-0027
18 Well Comb, 30 µL BIO-RAD #345-0028
Electrophoresis chamber, Criterion Cell BIO-RAD
Protein transfer, Trans-Blot Cell BIO-RAD
Power supply, PowerPac HC BIO-RAD
Protein Assay Kit BCATM Pierce #23225
Odyssey® Infrared Imaging System Li-COR Biosciences
Cell fraction buffers
Buffers adapted from the kit Qproteome Cell Compartment, Qiagen #37502
Cytosol buffer Buffer CE1 (Qiagen) 220 µL
Calyculin A (Upstate #19-139) 2.2 µL
Protease Inhibitor (Qiagen) 2.2 µL
Membrane buffer Buffer CE2 (Qiagen) 220 µL
Calyculin A (Upstate #19-139) 2.2 µL
Protease Inhibitor (Qiagen) 2.2 µL
Nucleus buffer Buffer CE3 (Qiagen) 110 µL
Calyculin A (Upstate #19-139) 1.1 µL
Protease Inhibitor (Qiagen) 1.1 µL
3.1.2 Cell culture
The cell line ReNcell VM is derived from the ventral mesencephalon of a ten week old hu-
man fetus and is immortalized by retroviral transduction with v-Myc oncogene (ReNeuron
Ltd, Guildford, UK). ReNcell VM cells were cultivated according to the previous described
protocol [Hoffrogge et al., 2006]. Briefly, cells were cultured in proliferation medium with
laminin (10 µg/mL) coated cell culture flasks T75, and maintained at 37 Celsius degrees with
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5% CO2.The medium was changed every two to three days. Proliferating cells were passaged
when confluence reached approximately 80%. For initiation of differentiation cells were washed
once with HBSS (15 mL) before differentiation medium was added (15 mL). For experiments
with Wnt3a treatment, 100 ng/mL of recombinant mouse Wnt3a were added to proliferation or
differentiation media.
Cells were harvested either in proliferating state (time point 0 hour) or at time points 0.5, 1,
2, 3, 4, 8, 12, 24, 48 and 72 hours after differentiation. Cells were detached from the flasks by
addition of Trypsin-Benzonase solution (2.5 mL per flask T75). The flasks were incubated at
37 degrees for three to five minutes. Addition of trituration solution (5 mL per flask) ensured
to stop the effect of the Trypsin. The cells in suspension were collected and pelleted by
centrifugation (1500 rpm for five minutes at room temperature). The supernatant was discarded
and cells were resuspended in 5 mL of ice-cold PBS with addition of the phosphatase inhibitor
Phosphostop (1 tablet/10 mL of PBS) and directly used for subcellular fractionation or stored
at -80 degrees.
3.1.3 Cell volume
ReNcell VM cell volume was calculated using the cell counter CASY® device. After
trypsination ReNcell VM cells are in nearly spherical shape in the solution suspension. This
condition is necessary and sufficient for the device CASY® to retrieve the mean volume of the
cells analyzed in the sample. As the solution Trypsin-Benzonase-trituration is isotonic it does
not produce cell volume changes. Cell suspension (25 µL) was diluted in 10 mL of CasyTon
buffer and analyzed by CASY®. The results given contain the mean volume (in femtolitre) of
the spherical spheres passing through the capillary.
3.1.4 Subcellular fractions
Subcellular fractions were prepared using the kit Qproteome Cell Compartment (Qiagen) ac-
cording to the manufacturer’s instructions. However buffer volumes were adapted, see details in
Section 3.1.1. Briefly, cells resuspended in 5 mL ice-cold PBS/Phosphostop were centrifuged
for 5 minutes at 1200 rpm, and the pellet was resuspended in 224.4 µL of cytosol buffer and
incubated for 10 minutes at 4 degrees on an end-over shaker. After 10 minutes of centrifuga-
tion at 2000 rpm, the supernatant was kept and identified as the cytosol fraction. The pellet
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Figure 3.1: Representative Western-blot for the subcellular fractions. GRP78 and TIM23 are markers for the
membrane fraction. Lamin A/C is a marker for the nucleus fraction, two bands are detected by the antibody, the
upper one (white arrow head) at 74 kDa and the lower one (black arrow head) at 65 kDa. GAPDH, is mainly
present in the cytosol fraction.
was resuspended in 224.4 µL of membrane buffer and incubated for 30 minutes at 4 degrees
on an end-over shaker. After centrifugation for 10 minutes at 8000 rpm the supernatant con-
tained the membrane fraction. The pellet was resuspended with 7 µL Benzonase Nuclease and
13 µL distilled water, and incubated at room temperature for 15 minutes. After addition of
112.2 µL nucleus buffer and incubation for 10 minutes at 4 degrees on an end-over shaker, a
last centrifugation at 9000 rpm for 10 minutes separated the supernatant kept as the nucleus
fraction. Subcellular fractions were stored at -80 degrees. Purity of the membrane, cytosol
and nucleus fractions were analyzed by immunoblotting, 30 µg of proteins were loaded on a
SDS-polyacrylamide gel and blotted, as described in the Section 3.1.5. Detection was made
with antibodies against the specific compartmental marker proteins: the Translocase of the In-
ner Mitochondrial membrane (TIM23) and the glucose-regulated protein 78 (GRP78) for the
membrane fraction; the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) for the cytoso-
lic fraction and the lamin A/C for the nuclear fraction. Antibodies details can be found in Table
3.3. Notice that GAPDH is also present in the membrane fractions, as mentioned by the manu-
facturers, but to a least extend than in the cytosolic fractions.
3.1.5 Protein determination & Western blot analysis
Protein concentrations of subcellular fractions were estimated using the protein assay kit
BCATM (Pierce) according to the manufacturer’s instructions. Afterwards, cell samples were
diluted in Laemmli-buffer 5 fold and boiled at 95 degrees for five minutes. Lysates were loaded
into gradient (4-15%) SDS-polyacrylamide gels (10-50 µg of proteins per lane) and separated
electrophoretically (BIO-RAD, Hercules, USA) for two hours (120 Volts). The prestained peq-
GOLD marker IV (PEQLAB, Erlangen, Germany) was used as molecular weight marker.
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Antibody name Reference Dilution
Mouse anti β-catenin Santa Cruz #7963 1:1000
Rabbit anti Dishevelled-2 Cell Signaling #3216 1:4000
Rabbit anti LRP6 Cell Signaling #2560 1:4000
Rabbit anti phospho-LRP6 (Ser1490) Cell Signaling #2568 1:2000
Mouse anti GSK-3β BD Transduction Laboratories #610201 1:1000
Mouse anti GSK-3β (pY216) BD Transduction Laboratories #612312 1:1000
Mouse anti Tim23 BD Transduction Laboratories #611222 1:1000
Mouse anti Lamin A/C BD Transduction Laboratories #612163 1:1000
Goat anti GRP78 (N-20) Santa Cruz Biotechnology #1050 1:2000
Rabbit anti GAPDH Santa Cruz Biotechnology #25778 1:2000
Rabbit anti β-actin Delta Biolabs #070 1:1000
Table 3.3: Primary antibodies used for protein detection by Western-blot
Antibody name Reference Dilution
Goat anti rabbit Alexa Fluor 680 Invitrogen #A-21076 1:10000
Goat anti mouse Alexa Fluor 680 Invitrogen #A-21057 1:10000
Rabbit anti mouse Alexa Fluor 680 Invitrogen #A-21065 1:10000
Donkey anti goat Alexa Fluor 680 Invitrogen #A-21084 1:10000
Rabbit anti mouse IRDye 800 Rockland #610-431-020 1:10000
Goat anti rabbit IRDye 800 Rockland #611-131-122 1:10000
Goat anti mouse IRDye 800 Rockland #610-131-003 1:10000
Table 3.4: Secondary antibodies used for fluorescence analysis of Western-blot
Proteins separated into the gel were transferred using a wet transfer system (BIO-RAD,
Hercules, USA) onto nitrocellulose membranes for one hour. After transfer, the membranes
were blocked with blocking solution I or II for detection of phosphorylated proteins (details in
Section 3.1.1) for one hour on a shaker, before incubation with the primary antibodies (Table
3.3). Antibodies were diluted in 1°Antibody buffer (Section 3.1.1) and membrane incubation
was done overnight at 4 degrees on a shaker. Meanwhile, the blotting gels were stained with
Colloidal Coomassie solution for verification of the amount of protein uploaded. Membranes
were rinsed three times, for five minutes each time, with TBST and probed with appropriate
fluorescent secondary antibodies (Table 3.4) diluted in 2°Antibody buffer I or II for detection of
phosphorylated proteins, one hour at room temperature on a shaker and in the dark. Membranes
were washed two times for five minutes each with TBST and once with TBS, before set to dry in
the dark. Visualization and quantification of proteins were performed using Odyssey® Infrared
Imaging System.
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3.1.6 Quantification & statistics
For quantification of proteins of interest the samples were loaded onto the gel in randomized
and non-chronological order to reduce systematic errors [Schilling et al., 2005]. The strategy
was developed with support from Katja Rateitschak (Department of Systems Biology & Bioin-
formatics, University of Rostock). Expressions of β-actin or GAPDH proteins were used as
loading controls to normalize the proteins of interest’s expressions. Thereby relative expression
levels of the target proteins were determined.
In order to be compared, the quantification of a given protein in different subcellular fractions
should have the same internal standard. The use of β-actin as loading control in the membrane
fraction is not possible due to the cytoskeletal changes in ReNcell VM cells during differentia-
tion. It is noteworthy that although GAPDH is a marker for cytosol fraction (see Section 3.1.4),
it is used as a loading control for both membrane and cytosol fractions, due to its ubiquitous
presence [Tarze et al., 2007] and its stability in the cytosolic fraction over the kinetics of the
experiments. To illustrate the stability of GAPDH in both fractions the standard error on the
mean (SEM) for GAPDH, over time and for 3 independent experiments (cell passages), was
calculated: SEM of 5.7 % and 7.3% are found in cytosol and membrane fractions, respectively.
For every single experiment, a SEM above 10% was ground for excluding the data from the
quantification.
For each quantified Western-blot, the relative expression at a given time point is normalized
to the mean of the time series. The resulting values were normalized to the one in proliferating
cells (time point 0 hour) that is set to 1. Normalization and rescaling methods were developed
with support from Yvonne Schmitz (Department of Systems Biology & Bioinformatics, Uni-
versity of Rostock). Results are expressed as means ± SEM. Experiments were reproduced at
least three times: three independent cell passages and at least three independent Western-blots
for each cell passage. Statistical evaluation was carried out using a two-tailed Student's t-test for
normally distributed data. Difference was considered to be statistically significant when p-value
was inferior to 0.05 (p ≤ 0.05).
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3.2 Spatio-temporal dynamics of Wnt signaling proteins
In attempt to analyze Wnt/β-catenin pathway activity during the pivotal passage from prolifer-
ation to differentiation of ReNcell VM cells, investigation of the spatio-temporal dynamics of
the main signaling proteins is performed. The proteins of interest are the co-receptor LRP6,
the enzyme GSK3β, Dvl2 and β-catenin. This choice is due, on one hand, to the importance
and specificity of these proteins for Wnt signaling (see Section 1), and on the other hand, to
their inaccessibility via the experimental techniques described previously (see Section 3.1, i.e.
the protein Axin could not be detected with Western-blot in ReNcell VM cell fractions.). Di-
verse protein states are investigated with the help of different antibodies (details in Table 3.3):
total LRP6 (t-LRP6) and LRP6 phosphorylated on serine 1490 residue (p-LRP6), total GSK3β
(t-GSK3β)and GSK3β phosphorylated on tyrosine 216 residue (p-GSK3β), total Dvl2 distin-
guish mature Dvl2 form (m-Dvl2) and phosphorylated Dvl2 (p-Dvl2), and total β-catenin. To
observe the spatial dynamics these proteins are quantified in their specific subcellular locations:
t-LPR6 and p-LRP6 in the membrane fraction, t-GSK3β in the cytosol fraction, total Dvl2 and
p-GSK3β in the membrane and cytosol fractions, and total β-catenin in the cytosol and nucleus
fractions. The temporal dynamics are investigated by quantification of the protein expressions,
in their respective locations, along the first three days of differentiation. After three days of
proliferation (time point 0 hour) in presence of growth factors, the cells were incubated with
differentiation media (without growth factors) before their collection after 0.5, 1, 2, 3, 4, 8
hours (early differentiation), and after 12, 24, 48, and 72 hours (late differentiation). The tem-
poral distinction between early and late differentiation is done regarding ReNcell VM cell fate
commitment as proposed by [Bader, 2010]: during early differentiation no distinction between
neurons and glial cells is yet possible, in contrast to the late differentiation. The data presented
are relative changes over time, compared to the amount at time 0 hour (proliferation) which is
set to 1. Each protein has been quantified in a minimum of four independent cell samples with
at least three quantitative Western-blots per cell sample.
3.2.1 Early regulation during the first hours of differentiation
Total LRP6 (t-LRP6) is already detectable in proliferation with two specific bands: the lower
one at 180 kilodalton (kDa) represents LRP6 in the endoplasmic reticulum (ER) (ER-LRP6,
black arrowhead on Figure 3.2a), and the upper band at 190 kDa shows the mature LRP6 (m-
LRP6, white arrowhead, Figure 3.2a) in the membrane fraction. As early as 0.5 hour after
differentiation, t-LRP6 increases significantly to 1.25 fold compared to the proliferation control.
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(a) t-LRP6 and p-LRP6
(b) Quantification of t-LRP6 (c) Quantification of p-LRP6 ser1490
Figure 3.2: Analyses of LRP6 protein in the membrane fraction during ReNcell VM cell differentiation. (a)
Representative Western-blots of t-LRP6 and p-LRP6 in membrane fraction. For t-LRP6 white arrowhead point
to mature LRP6 (m-LRP6) and black arrowhead points to LRP6 in endoplasmic reticulum (ER-LRP6). (b,c)
Quantified Western-blot analyses of total LRP6 (t-LRP6) (b) and LRP6 phosphorylated on serine 1490 (p-LRP6)
(c) in membrane fraction. Time point 0 hour stands for control using proliferating cells. GAPDH is used as a
loading control. The signal intensity at 0 hour is set to 1 and used to normalized the intensity for the other time
points. Values are presented as mean ± SEM from at least 3 independent experiments. For statistical significance
‘*’ stands for p-value <0.05, and ‘**’ for p-value <0.01 compared to control (0 hour).
It is followed by a slow decrease reaching a level of 0.77 fold after 4 hours that remains almost
constant until 12 hours of differentiation (Figure 3.2b). The detection of p-LRP6 shows a weak
expression during proliferation that remains stable along the first 12 hours of differentiation
(Figure 3.2c).
Dvl2 is also detected in Western-blot with two bands [Bryja et al., 2007b, Hübner et al.,
2010]: The upper one, the phosphorylated Dvl2 at 95 kDa (p-Dvl2, white arrowhead on Figure
3.3a and 3.10d), and the lower one, the mature Dvl2 at 90 kDa (m-Dvl2, black arrowhead,
Figure 3.3a and 3.10d). It is noticeable that in the membrane fraction, more than two bands are
detected for Dvl2, which might be due to various forms of Dvl2 contained in diverse membrane-
enclosed organelles. In the membrane fraction the level of Dvl2 is very low during proliferation
but increases significantly from 0.5 to 12 hours. Two peaks are observed at 2 hours and 12 hours
with similar levels for p-Dvl2 and m-Dvl2, i.e. 1.75 and 1.57 fold increase, respectively (Figure
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(a) Dvl2 in the membrane fraction
(b) Dvl2 in the cytosol fraction
(c) Quantification of the membrane fraction (d) Quantification of the cytosol fraction
Figure 3.3: Analyses of Dvl2 protein in the membrane and cytosol fractions during ReNcell VM cell differ-
entiation. (a,b) Representative Western-blots of Dvl2 in membrane (a) and cytosol (b) fractions. White arrowheads
point phophorylated Dvl2 (p-Dvl2) and black arrowheads point mature Dvl2 (m-Dvl2). (c,d) Quantified Western-
blot analyses of p-Dvl2 and m-Dvl2 in membrane (c) and cytosol (d) fractions. GAPDH is used as a loading
control. Normalization and statistical analyses were performed as described in Figure 3.2.
3.3c). Contrarily, in the cytosol fraction, the level of Dvl2 stays stable along the first 8 hours of
differentiation, and in response to the increase at 12 hours in the membrane, a decrease to 0.73
fold of p-Dvl2 in the cytosol is observed (Figure 3.3d).
Analyses of total GSK3β do not show variation over time in the cytosol fraction (Figure
3.4b). This could be expected since GSK3β is a kinase and it is its level of in/activation that
is expected to change rather than the total amount of molecules [Papkoff and Aikawa, 1998].
Detection of active-phosphorylated GSK3β on tyrosine 216 amino acid with a specific antibody
(see Table 3.3) reveals two bands: the upper one is GSK3α phosphorylated on tyrosine 279 at
51 kDa (p-GSK3α), the lowest one is GSK3β phosphorylated on tyrosine 216 at 47 kDa (p-
GSK3β) [Kotliarova et al., 2008]. In the membrane fraction, a significant decrease of p-GSK3β
at 3 and 8 hours is observed (Figure 3.5c), as well as an increase of p-GSK3α in the cytosol
fraction at 3 hours (Figure 3.5d).
Total β-catenin varies in the different compartments. In the cytosol fraction a first significant
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(a) total GSK3β
(b) Quantification of total GSK3β
Figure 3.4: Analyses of GSK3β protein in the cytosol fraction during ReNcell VM cell differentiation. (a)
Representative Western-blot of total GSK3β in the cytosol fraction. (b) Quantified Western-blot analyses of total
GSK3β in cytosol fraction. GAPDH is used as a loading control. Normalization and statistical analyses were
performed as described in Figure 3.2.
decrease to 0.79 fold is observed after 1 hour of differentiation (Figure 3.6c), whereas in the
nucleus fraction β-catenin level increases, at the same time point, up to 1.47 fold (Figure 3.6d).
Afterwards, the level of cytosolic β-catenin stays stable around the proliferation level until 8
hours of differentiation. Nuclear β-catenin declines at 2 hours, before a gradual increase which
reach 1.53 fold at 8 hours and 1.72 fold at 12 hours.
3.2.2 Late response during the first days of differentiation
After 24 hours of differentiation, LRP6 shows a significant increase compared to the level at 12
hours (Figure 3.2b), and p-LRP6 rises of 1.34 fold (Figure 3.2c). Besides, a change of LRP6 is
observed as the ER-form (band at 180 kDa) increases at 24 hours, and at 72 hours the two bands
are close to each other around 180 kDa. An equivalent change is observed for p-LRP6, with the
detection on the Western-blot of a second band at 24 hours, and a shift of the band from 200
kDa to 190 kDa at 72 hours.In the membrane fraction, both m-Dvl2 and p-Dvl2 are expressed at
very low level, close to proliferation level, between 24 and 72 hours (Figure 3.3c). Similarly, in
the cytosol fraction, m-Dvl2 and p-Dvl2 levels are low and below the proliferation level from 24
hours onward (Figure 3.3d). Only at 72 hours, in the membrane fraction, a decrease of pGSK3α
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(a) p-GSK3α/β in the membrane fraction
(b) p-GSK3α/β in the cytosol fraction
(c) Quantification of the membrane fraction (d) Quantification of the cytosol fraction
Figure 3.5: Analyses of phosphorylated GSK3α/β proteins in the membrane and cytosol fractions during
ReNcell VM cell differentiation. (a) Representative Western-blot of phosphorylated GSK3α/β proteins, white
arrowhead points to p-GSK3α, and black arrowhead points to p-GSK3β . (b,c) Quantified Western-blot analyses
of p-GSK3α and p-GSK3β in membrane (b) and cytosol (c) fractions. GAPDH is used as a loading control.
Normalization and statistical analyses were performed as described in Figure 3.2.
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(a) β-catenin in the cytosol fraction
(b) β-catenin in the nucleus fraction
(c) Quantification of the cytosol fraction (d) Quantification of the nucleus fraction
Figure 3.6: Analyses of β-catenin protein in the cytosol and nucleus fractions during ReNcell VM cell dif-
ferentiation. (a,b) Representative Western-blots of β-catenin in the cytosol (a) and nuclear (b) fractions. (c,d)
Quantified Western-blot analyses of β-catenin protein in cytosol (c) and the nucleus (d) fractions. β-actin is used
as a loading control. Normalization and statistical analyses were performed as described in Figure 3.2.
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is observed (Figure 3.5c). Finally, cytosolic β-catenin is increasing from 24 hours onward, to
reach a peak around 2.5 fold at 72 hours (Figure 3.6c). In the nucleus, the increase, already
visible at 8 hours, endures to reach 1.6 fold increase at 24 hours, and 2.7 fold at 48 and 72 hours
(Figure 3.6d).
3.3 Protein dynamics under Wnt3a stimulation
In a second set of experiments the protein dynamics were analyzed under the pathway stimula-
tion with Wnt3a, known to trigger Wnt/β-catenin pathway. The changes in response to Wnt3a
stimulation are compared to the physiological response in order to understand the effects of
Wnt3a stimulation on protein abundance and relocation. ReNcell VM cells were treated with
Wnt3a (100 ng/ml) during proliferation and differentiation. After three days of proliferation,
the cells were collected for control (proliferation, time 0 hour), and either incubated in prolifer-
ation media with Wnt3a for 3 hours (proliferation with Wnt3a), or incubated in differentiation
media with Wnt3a for 0.5, 1, 3, 24 and 48 hours and harvested after the respective incubation
time. The rest of the experimental setting stays as described previously in Section 3.2.
3.3.1 Wnt3a influences during proliferation
Three hours after proliferation with Wnt3a, no significant changes are detected for LRP6,
p-LPR6, and Dvl2 in the membrane fraction compared to the control (proliferation without
Wnt3a) (Figures 3.7a-3.7d, and 3.7b- 3.7e). The same holds true for the level of p-GSK3α and
p-GSK3β, both in membrane and cytosol fractions (data not shown). In contrast, in the cytosol
fraction, a hyper-phosphorylation of Dvl2 is observed with the mobility shift resulting in the
absence of m-Dvl2 (90 kDa) and the increase of p-Dvl2 (95 kDa) (Figures 3.7b, 3.7e). It is ac-
companied by an increase of β-catenin to 1.36 fold in the cytosol, and to 1.6 fold in the nucleus
(Figures 3.7c, 3.7f). It is noticeable that the cell proliferation is not affected by Wnt3a presence,
and that no differentiation’s phenotype, e.g. cell elongation, can be seen during the three hours
of Wnt3a treatment.
3.3.2 Wnt3a influences during differentiation
The detection of t-LRP6 in the membrane fraction shows the same temporal dynamics during
differentiation with and without (control) Wnt3a (Figure 3.8). On the contrary, a quick
increase of p-LRP6 is observed at 0.5 hours (1.64 fold) and remains high until 3 hours after
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(a) LRP6 (b) Dvl2 (c) β-catenin
(d) LRP6 (e) Dvl2 (f) β-catenin
Figure 3.7: Protein expression during ReNcell VM cell proliferation with Wnt3a. (a,b,c) are representa-
tive Western-blots of the proteins under proliferation with Wnt3a treatment (100ng/ml) (+) or without Wnt3a (-),
GAPDH or β-actin are used as loading control. (a) detection of LRP6 phosphorylated on serine 1490 residu (p-
LRP6) shows a band at 200 kDa (white arrowhead) in the membrane fraction and detection of total LRP6 (LRP6)
shows 2 bands, one at 190 kDa (white arrowhead) for the ER form (ER-LRP6) and one at 180 kDa (black arrow-
head) for the mature form (m-LRP6). (b) Dvl2 detected in the membrane and cytosol fractions, presents a band at
95 kDa (white arrowhead) for the phosphorylated form (p-Dvl2), and a band at 90 kDa (black arrowhead) for the
mature form (m-Dvl2). For Dvl2 in the cytosol fraction under Wnt3a treatment, no mature form is detected. (c)
detection of total β-catenin in cytosol and nucleus fractions. (d,e,f) Quantified Western-blot analyses during pro-
liferation with (Wnt3a) or without Wnt3a (control) treatment. The signal intensity at proliferation without Wnt3a
is the control for each protein and its value is set to 1. Values are presented as mean ± SEM from at least 3 inde-
pendent experiments. For statistical significance ‘*’ stands for p-value <0.05, ‘**’ for p-value <0.01, and ‘***’ for
p-value <0.001 compared to control (proliferation without Wnt3a).
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differentiation (Figure 3.9a). This intensification of p-LRP6 signal is accompanied by the shift
of the original band at 190 kDa to 210 kDa [Khan et al., 2007]. After 8 hours and during the
late differentiation the level of p-LRP6 declines down to 0.67 fold (Figure 3.9b).
In the membrane fraction, p-Dvl2 presents two transient peaks at 0.5 and 3 hours (1.46 and 1.38
fold increase), whereas m-Dvl2 shows a single increase at 0.5 hours and remains afterwards
close to the control level (at time 0 hour). In the cytosol fraction, p-Dvl2 dynamic does not dif-
fer from the physiological differentiation, whereas m-Dvl2 presents a highly regulated dynamic
in presence of Wnt3a: as early as 0.5 hours m-Dvl2 decreases and reaches a level of 0.33 fold at
3 hours. Later, at 8 and 48 hours m-Dvl2 exhibits two increases to 1.8 and 1.5 fold, respectively.
In the membrane fraction p-GSK3α and p-GSK3β increase significantly after 0.5 hours
of Wnt3a treatment during differentiation. It is followed by a decrease of p-GSK3α after 1 hour
of differentiation with Wnt3a and at 24 and 48 hours for p-GSK3β. In the cytosol fraction,
significant decreases of p-GSK3α occur at 1 and 3 hours compared to the differentiation
without Wnt3a at the same time points. Inversely, p-GSK3α increases significantly at 48 hours
after Wnt3a treatment. Two limited increases of p-GSK3β are observed at 8 and 48 hours of
differentiation with Wnt3a treatment.
Wnt3a influences the level of β-catenin as early as 0.5 hours after treatment with a sig-
nificant decrease down to 0.7 fold observed in the cytosol (Figure 3.12c) that contrasts with
a significant increase in the nucleus to 2.1 fold (Figure 3.12d). Levels of β-catenin increase
in the cytosol and in the nucleus to reach a level of 1.47 fold after 3 hours of differentiation
with Wnt3a. For the late differentiation, at 24 and 48 hours, β-catenin in both compartments
accumulates as observed during differentiation without Wnt3a (Figures 3.12a-3.12d).
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(a) t-LRP6
(b) Quantification of m-LRP6 (c) Quantification of ER-LRP6
Figure 3.8: Analyses of t-LRP6 protein in the membrane fraction during ReNcell VM cell differentiation
with Wnt3a. (a) Representative Western-blot of t-LRP6. (b,c) Quantified Western-blot analyses of LRP6 mature
form (m-LRP6) (b) and ER form (ER-LRP6) (c) in membrane fraction. GAPDH is used as a loading control.
Time point 0 hour stands for control using proliferating cells without Wnt3a. The signal intensity at 0 hour is set
to 1 and used to normalized the intensity for the other time points. Values are presented as mean ± SEM from
at least 3 independent experiments. For statistical significance ‘*’ stands for p-value <0.05, and ‘**’ for p-value
<0.01 compared to control (proliferation without Wnt3a).
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(a) p-LRP6
(b) Quantification of p-LRP6
Figure 3.9: Analyses of p-LRP6 protein in the membrane fraction during ReNcell VM cell differentiation
with Wnt3a. (a) Representative Western-blot of p-LRP6, white arrowhead points to the band at 210 kDa, and
the black arrowhead points to the band at 190 kDa. (b) Quantified Western-blot analyses of phophorylated LRP6
(p-LRP6) in membrane fraction. GAPDH is used as a loading control. Normalization and statistical analyses were
performed as described in Figure 3.8.
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(a) Dvl2 in the membrane fraction
(b) Quantification of p-Dvl2, membrane fraction (c) Quantification of m-Dvl2, membrane fraction
(d) Dvl2 in the cytosol fraction
(e) Quantification of p-Dvl2, cytosol fraction (f) Quantification of m-Dvl2, cytosol fraction
Figure 3.10: Analyses of Dvl2 protein in the membrane and cytosol fractions during ReNcell VM cell dif-
ferentiation with Wnt3a. (a,d) Representative Western-blots of Dvl2 in the membrane (a) and the cytosol (d)
fractions. (b,c,e,f) Quantified Western-blot analyses of phophorylated (p-Dvl2) (b,e) and mature (m-Dvl2) (c,f)
dishevelled 2 protein, in membrane (b,c) and cytosol (e,f) fractions. GAPDH is used as a loading control. Normal-
ization and statistical analyses were performed as described in Figure 3.8.
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(a) p-GSK3α/β in the membrane fraction
(b) Quantification of p-GSK3α, membrane fraction (c) Quantification of p-GSK3β, membrane fraction
(d) p-GSK3α/β in the cytosol fraction
(e) Quantification of p-GSK3α, cytosol fraction (f) Quantification of p-GSK3β, cytosol fraction
Figure 3.11: Analyses of phosphorylated GSK3α/β proteins in the membrane and cytosol fractions during
ReNcell VM cell differentiation with Wnt3a. (a,d) Representative Western-blots of phosphorylated GSK3α/β
in the membrane (a) and cytosol (d) fractions, white arrowhead points to p-GSK3α, and black arrowhead points to
p-GSK3β. (b,c,e,f) Quantified Western-blot analyses of p-GSK3α (b,e), and p-GSK3β (c,f) in membrane (b,c) and
cytosol (e,f) fractions. GAPDH is used as a loading control. Normalization and statistical analyses were performed
as described in Figure 3.8.
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(a) β-catenin in cytosol fraction
(b) β-catenin in nucleus fraction
(c) Quantification of β-catenin , cytosol fraction (d) Quantification of β-catenin , nucleus fraction
Figure 3.12: Analyses of β-catenin protein in the cytosol and nuclear fractions during ReNcell VM cell
differentiation with Wnt3a. (a,b) Representative Western-blot of β-catenin in the cytosol (a) and in the nucleus
(b) fractions. (c,d) Quantified Western-blot analyses of β-catenin in the cytosol (c) and nucleus (d) fractions. β-
actin is used as a loading control. Normalization and statistical analyses were performed as described in Figure
3.8.
43
3.4 Discussion
The present study reports on the spatio-temporal dynamics of Wnt/β-catenin signaling proteins
along the differentiation process of human neural progenitor cells, ReNcell VM cells. The
quantitative kinetic investigation of the signaling proteins shows their regulation during the
first three days of physiological differentiation and differentiation under Wnt3a treatment, a
trigger of Wnt/β-catenin pathway. The four proteins of interest are the co-receptor LRP6, Dvl2,
GSK3β, and β-catenin due to their prominent roles in the Wnt/β-catenin signaling pathway.
The present study focuses on protein dynamics at the physiological level. This is not a stan-
dard approach as some components are endogenously expressed at low level in cells and thus,
can be detected only with difficulty, e.g. Axin [Lee et al., 2003], and LRP6 [Khan et al., 2007].
However, any attempt to overexpress these components would invalidate the observed results.
Thus, there is a need to analyze the proteins regulation at physiological level. During physio-
logical differentiation, the protein dynamics follow biphasic kinetics with a first phase during
the first three hours of differentiation, and a second one between 24 and 72 hours of differen-
tiation, both separated by an intermediate steady level (Figure 3.13). The involvement of the
pathway is observed under physiological differentiation through the presence of the co-receptor
LRP6, the activation of Dvl2 at the membrane level, and the accumulation of β-catenin in the
cytosol and the nucleus. Wnt3a stimulation during differentiation increases protein abundance
and relocation as well as the nucleo-cytosolic shuttling of β-catenin.
3.4.1 Protein dynamics during differentiation
Phosphorylation of LRP6 on the PPP(S/T)P motifs is thought to trigger the pathway activation
[Tamai et al., 2004]. In the membrane fraction of the ReNcell VM cells, phosphorylation of
LRP6 on serine 1490 (p-LRP6) is observed only after 24 hours whereas an increase is observed
after 0.5 hours in presence of Wnt3a. Thus, an augmentation of serine 1490 phosphorylation
might not be necessary for Wnt signal transduction, as proposed by [Beagle et al., 2009, Wolf
et al., 2008] and p-LRP6 increase might occur only subsequently to Wnt3a stimulation. It is
noteworthy that the absence of signal can also be due to the sensitivity of the antibody used
that is too low to detect physiological levels of LRP6 phosphorylation. In the second phase of
protein dynamics, after 24 hours, t-LRP6 and p-LRP6 show significant changes. At the same
time point an increase of LRP6 mRNA is found by real-time PCR in ReNcell VM cells [Hübner,
2010, Mazemondet et al., 2011]. These results suggest that the increase of the ER form of
LRP6 at 24 hours reflects the receptor synthesis and turn-over. Furthermore, this rise of LRP6
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abundance can explain the presence of the second band detected by p-LRP6 antibody at 24
hours. Thus, the ReNcell VM cells are a good cell model to study the dynamics of the co-
receptor LRP6 in the regulation of the Wnt/β-catenin signaling pathway.
The massive increase of Dvl2 in the membrane fraction subsequent to differentiation reflects
the protein activation and recruitment in order to trigger the intracellular signaling cascade in
response to the Wnt signal [Axelrod et al., 1998]. In ReNcell VM cells this recruitment is
subject to dynamic regulation as shown by the biphasic kinetics with peaks at 2 and 24 hours.
These observations suggest that Wnt signaling pathways are active at diverse stages of ReNcell
VM cell development, i.e. early and late differentiation. Thus, the apparent absence of Dvl2 in
the membrane fraction during proliferation and after 24 hours of differentiation appears to be
associated with the pathway inactivity. Indeed, in mouse neuron-like dopaminergic cells, the
absence of Dvl2 is associated to an inhibition of the Wnt ligand endocytosis, leading to a down-
regulation of the signaling pathway [Bryja et al., 2007a]. Hence, the disappearance of Dvl2
after 24 hours that accompanies the change of LRP6, especially the low detection of the mature
form, can illustrate a negative feedback as proposed by [Bryja et al., 2007a], shown here for the
first time in human neural progenitor cells. In comparison to the physiological differentiation,
the presence of Wnt3a during differentiation does not impact the dynamics of Dvl2 in the mem-
brane. In contrast, Wnt3a affects Dvl2 in the cytosol. As shown in dopaminergic neuronal cell
line [Bryja et al., 2007b], Wnt3a induces the phosphorylation-dependent Dvl mobility shift as
observed by the presence of a single band in the Western-blot at the level of p-Dlv2. Interest-
ingly, in ReNcell VM cells this mobility shift of Dvl2 is similar to the one observed previously.
However, the present analyses show that such event occurs only in the cytosol.
The amount of GSK3β does not change over time as it is often the case for kinases: the kinase
pool remains constant and only the enzymatic activity varies. However, during physiological
differentiation, no significant changes in the amount of active GSK3α/β have been found. Thus,
the activation of GSK3α/β in the T-loop might not be necessary for the transduction of the Wnt
signal.
β-catenin is submitted to high spatio-temporal dynamics during ReNcell VM cell differen-
tiation. The increase of nuclear β-catenin during the first hour of differentiation is correlated
to the decrease at the same time point in the cytosol, predicting a shuttle of β-catenin from the
cytosol to the nucleus activated quickly after the beginning of differentiation. It is known that
this trafficking is observable in kinetic studies previously to β-catenin accumulation [Hendrik-
sen et al., 2008]. Interestingly, no accumulation of β-catenin in the cytosol prior to 24 hours
could be detected, which leads to the hypothesis that non-phosphorylated β-catenin shuttles im-
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mediately to the nucleus, whereas accumulation happens in the late differentiation phase, after
24 hours.
An overview of the protein spatio-temporal dynamics during ReNcell VM cell physiological
differentiation is shown in Figure 3.13.
3.4.2 Pathway dynamics under Wnt3a stimulation
Due to the short half-life of Wnt3a (1.9 hours), its effects are observable mainly during the early
differentiation of ReNcell VM cells. The spatio-temporal dynamics of the signaling proteins
under Wnt3a stimulation have been investigated in mouse F9 teratocarcinoma cells [Yokoyama
et al., 2007] and the results differ from the one observed here. This emphasizes the importance
of investigating these aspects in every specific cell line, as the pathway is differently regulated
in each cell type and at different stages of cell development. However, the common effect of
Wnt3a on the protein kinetics, in ReNcell VM cells as well as in F9 cells, is the acceleration
of protein recruitment and activation such as the acceleration of β-catenin transfer from the
cytosol to the nucleus. Also, the early increase of β-catenin in the nucleus after 0.5 hours
of Wnt3a stimulation has been observed in diverse cell systems [Yokoyama et al., 2007, Hen-
driksen et al., 2008]. Differences in protein activation are observed between physiological and
Wnt3a-stimulated differentiation. In the latter a significant protein activation is observed as
early as 0.5 hours after addition of Wnt3a with an increase of p-GSK3α/β, p-LRP6 and Dvl2
in the membrane fraction and of nuclear β-catenin associated with a decrease of cytosolic β-
catenin (Figure 3.14). Effects of Wnt3a are still visible after 3 hours of treatment with a second
peak of nuclear β-catenin, in this case associated with an increase of cytosolic β-catenin and
the phosphorylation-dependent Dvl2 mobility shift in the cytosol. Treatment for 3 hours with
Wnt3a in proliferating or differentiating ReNcell VM cells leads to different effects: equiva-
lent increases of β-catenin in cytosol and nucleus are observed during both cellular processes.
However, these accumulations seem to result from diverse processes as during proliferation
no significant phosphorylation of LRP6 is observed in contrary to differentiation. This sug-
gest that Wnt3a can trigger both phosphorylated LRP6 dependent and independent activation
of β-catenin in the same cell line depending of the cell-stage. Thus, high amount of Wnt3a
(100 ng/ml) significantly seems to change the dynamics of signaling proteins that can influence
cell phenotype. However, this hyptothesis should be subject to future investigations in ReNcell
VM cells in order to be confirmed.
An overview of the protein spatio-temporal dynamics during ReNcell VM cell differentiation
in presence of Wnt3a is shown in Figure 3.14.
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3.4.3 Nuclear β-catenin dynamics
During ReNcell VM cell differentiation, the signaling proteins of the Wnt/β-catenin pathway
are subject to dynamic regulations especially nuclear β-catenin. After one hour of differentia-
tion an increase is observed subsequent to the Wnt signal as confirmed by the experiments with
Wnt3a. However, it remains unclear if the later increase, starting after 8 hours is due to a second
signal of Wnt molecules or due to some other changes in the cell environment.
A first hypothesis arises with the other observations made in ReNcell VM cells. As men-
tioned previously (see Section 2.2.2), the ReNcell VM cells do not start their differentiation at
the same time after growth factor removal. This is due to the asynchrony of the cell population,
i.e. the heterogeneity regarding their progression in the cell cycle. Indeed when the growth
factors are removed from the media, only 53% of the cells can start their differentiation and be
sensitive to the presence of Wnt molecules in the environment. Between 12 and 24 hours of
differentiation all the remaining cells, i.e. 43%, reach G1 phase and can then be receptive to
Wnt signal. Does this asynchrony explain the second increase from 8 hours onward observed
for nuclear β-catenin ? Further experiments on ReNcell VM cells, such as cell synchronization
with the chemical molecule nocodazole, have been tested (oral communication with Dr. M.
Frech). Although the synchronization of the cells was successful the collateral damages, e.g.
cell instability, and high death rate, made the synchronized ReNcell VM cells not suitable for in
vitro exploration. Thus, so far, in vitro exploration of the ReNcell VM cell asynchrony effects
onto nuclear β-catenin dynamics cannot be performed.
Another explanation for this second increase of nuclear β-catenin could be a self-induced
Wnt signal. As morphogens, Wnt molecules are produced by the cells and exported in the cell
field to propagate their signal (see Section 2.1.1 for details). In ReNcell VM cells, production of
Wnt molecules such as Wnt5a or Wnt7a mRNA increases between 6 and 24 hours of differen-
tiation [Mazemondet et al., 2011]. Thus, the second increase of nuclear β-catenin could reflect
an increase of Wnt molecules production, secretion, and propagation in the population leading
a second response of the cells to Wnt signal. However, isolation and analysis of endogenous
Wnt proteins in the cell medium are nontrivial experiments.
As an alternative to time and fund consuming experiments, and in order to test the accuracy
and validate the two given hypotheses, a computational model of the Wnt pathway in ReNcell
VM cell populations is built to further investigate nuclear β-catenin dynamics.
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Figure 3.13: Overview of protein dynamics during physiological differentiation of ReNcell VM cells. Plots are ordered depending on the protein quantification
in the respective subcellular location: M stands for the membrane, C for the cytosol, and N for the nucleus fractions The scale of the X-axis is logarithmic.
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Figure 3.14: Overview of protein dynamics during differentiation of ReNcell VM cells with Wnt3a. Plots are ordered depending on the protein quantification
in the respective subcellular location: M stands for the membrane, C for the cytosol, and N for the nucleus fractions The scale of the X-axis is logarithmic.
Chapter 4
in silico validation
In this chapter a computational model of the Wntβ-catenin pathway in ReNcell VM cell popula-
tions is presented. It aims to explore the impact of the cell cycle and of self-induced Wnt signal,
on the nuclear β-catenin dynamics observed in vitro (see Section 3). Section 4.1 presents the
related work and the reference model. The model of the intracellular Wnt/β-catenin pathway in
ReNcell VM cells is presented in Section 4.2. Section 4.3 shows the methods used to obtain the
model parameters. Sections 4.4 and 4.4.3, respectively, present the model evaluation and the
parameters’ impact on the model behavior. Stochastic analyses of the model and the results of
the in silico experiments are provided in Section 4.5.
4.1 Existing Wnt/β-catenin pathway models
4.1.1 Lee et al. (2003)
Due to its complexity and the lack of published quantitative data, the Wnt signaling pathway was
not the first choice for modeling experts. Nevertheless, in 2003, Krüger and Heinrich proposed
the first mathematical and deterministic model of the Wnt/β-catenin pathway, in the Xenopus
oocyte. In the following, it will be refered as the Lee model. Moreover, the originality of this
model resides in the combination of estimated, experimentally retrieved and derived kinetic
parameters. The use of Xenopus oocyte, as an experimental system, presents the advantages to
be essentially cytoplasm, well-stirred and synchronous, the way a cell population is not.
The Lee model describes the pathway reaction network, in a single cell with one compart-
ment, expressed as a set of ordinary differential equations (ODEs). Initially composed of 15
ODEs, the model is reduced to 7 ODEs and 8 algebraic equations using approximations and
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assumptions described in [Krueger and Heinrich, 2004].
The Lee model contains the following species: Dishevelled (called Dsh in Xenopus), GSK3β,
APC, Axin, β-catenin (total and phosphorylated), and TCF (Figure 4.1). The events happening
at the plasma membrane are omitted and the pathway activation via Wnt is represented by the
activation of Dsh (reaction 1 in Figure 4.1). All the species concentrations, except phosphory-
lated β-catenin, were determined experimentally by Western-blot. The concentrations of Dsh,
GSK3β, APC and TCF are considered to be constant over time. Only Axin and β-catenin are
the two species constantly produced and degraded.
The reactions between species describe the following processes: protein synthesis and degra-
dation, de-/phosphorylation, and protein complex dis-/assembly. These reactions follow differ-
ent kinetics: the synthesis of Axin and β-catenin are described as flux. They are respectively
represented by the constant rates v12 and v14 (Figure 4.1). The unimolecular reactions (single
headed arrows in Figure 4.1) follow mass action kinetics, described by a first order rate con-
stant. Simplification is made for the reversible steps (double headed arrows in Figure 4.1): it
is assumed that the binding step is faster than the unbinding one. Thus, a reversible reaction
is only characterized by the dissociation step and only the dissociation constant is needed to
describe the reaction. This limits the amount of parameters needed, leaving aside the ability to
describe the reaction kinetics.
Among the model results, the authors show that their model predictions are fitting exper-
imental data performed in the Xenopus oocyte. The main insight concerns the role of Axin,
proposed as the crucial component of the degradation complex. Indeed, the quantitative exper-
iments done by Lee and co-authors measured a lower concentration of Axin compared to the
other species of the degradation complex, i.e. 0.02 nM versus 50 nM for GSK3β and 100 nM
for APC. The in silico experiments show that Axin turnover affects the amplitude and duration
of β-catenin level under transient Wnt stimulation. Thus, according to the Lee model Axin is
the limiting factor in β-catenin degradation process.
4.1.2 Lee model extensions
The Lee model is a reference regarding Wnt pathway’s computational modeling approach, and
is used as a basis for further model attempts.
Cho et al. (2006) A first extension was done by [Cho et al., 2006], who added the negative
feedback loop due to Axin production (referred as Axin2 in the paper). Whereas the Lee model
only refers to the binding of β-catenin to TCF, Cho and co-authors assume that the species
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Figure 4.1: The reaction steps of the Wnt pathway (reproduced from [Lee et al., 2003], Figure 1). Protein
complexes are denoted by the names of their components. Phosphorylated components are marked by an asterisk.
Single-headed solid arrows characterize reactions taking place only in the indicated direction. Double-headed
arrows denote binding equilibrium. The broken arrows indicate that the components mediate, but do not participate
in, the reaction scheme. The irreversible reactions 2, 4, 5, 9-11, and 13 are unimolecular, and reactions 6, 7, 8, 16,
and 17 are reversible binding steps.
β-catenin and β-catenin/TCF are inducing Axin synthesis. This reaction follows mass action
kinetics. This model aims to observe the impact of various APC mutations, as these are associ-
ated to colon cancer. The mutations are represented by a variation of the parameter values. The
authors conclude that the APC mutations are selected based on an optimal level of β-catenin
which is determined by a specific balance between its increase consecutively to the pathway
activation and its decrease due to Axin feedback. Limitations of this model include the as-
sumption that both free β-catenin and β-catenin complexed to TCF produce Axin: in biological
systems only the second holds true.
Wawra et al. (2007) Hereby, the authors propose a robustness analysis and an extension of
the Lee model [Wawra et al., 2007]. The robustness of the Lee model is tested by single and
multiple parameter perturbations as well as initial condition variation. These analyses reveal
robustness of the steady-state and dynamic shape of β-catenin time plots.
With their extension the authors aim to test whether intrinsic oscillations of the Wnt/β-
catenin pathway can occur. They refer to vertebrate somitogenesis, i.e. formation of vertebral
column and muscles during early development, a process during which oscillating Wnt pathway
is observed.
Similar to the Cho model, the extension of this model concerns the addition of negative feed-
back loops, as they are known to down-regulate the signaling cascade, and have been proposed
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to produce oscillation [Kholodenko, 2000]. However, their approach differs from the previous
one in the more detailed description of the two feedback loops engendered by production of
Axin and of a pathway inhibitor protein, such as Dickkopf 1 (Dkk1). The gene transcription is
assumed to be a cooperative activation and is described by sigmoidal Hill function. The model
integrates the intermediate products of the reactions, such as Axin RNA and Dkk1 RNA. The
authors add delays to represent the time needed by the biological processes for transcription
(copy of the DNA into RNA), splicing (modification of the RNA), translation (RNA transfor-
mation into protein), and diffusion (passage of the RNA from the nucleus to the cytosol). Thus,
the addition of delays turns the system of ODEs into a system of delay differential equations
(DDEs).
The analysis of this extended model, with the original parameters of the Lee model, under
permanent Wnt signal, does not show stable oscillations. Furthermore, the steady-state of β-
catenin is decreasing of 38% compared to the level observed in the Lee model, i.e. from 25.01
nM to 15.51 nM. These primary observations lead to the conclusion that a higher turn-over
of β-catenin and Axin is necessary to reach an oscillation threshold. The modification of the
corresponding parameters, i.e. an increase between 2 and 20 fold of the values provided in
the Lee model, leads to oscillations of β-catenin and β-catenin/TCF, Axin2 RNA and inhibitor
RNA. However, the authors report that compared to the oscillations observed in vivo, the ones
observed in silico are longer, and this can be due to additional mechanisms not included in the
model. Through their model, Wawra and co-authors show that oscillations of the Wnt/β-catenin
pathway can occur independently of the environment and external influences.
van Leeuwen et al. (2007) This model focuses on β-catenin and the balance between its
adhesion and transcription functions [van Leeuwen et al., 2007]. A set of ODEs describes the
different conformations and binding states of β-catenin. As in the Lee model, the reactions
take place in a single cell compartment although in biological systems β-catenin functions are
subcellular location-dependent: adhesion occurs at the plasma membrane and transcription oc-
curs in the nucleus. Via in silico experiments, the authors tested two hypotheses concerning
β-catenin fate between these two functions: either the proteins binding to β-catenin determine
the fate, or it is governed by the conformational change of β-catenin itself. Their analyses
suggest that the second hypothesis is the most probable.
Mirams et al. (2010) The authors propose a systematic asymptotic analysis of the Lee model
[Mirams et al., 2010]. This mathematical analysis aims to reduce the number of parameters
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used in the model. Thus, the original set of ODEs from the Lee model is reduced to a single
simplified ODE, that represents the dynamics of β-catenin (denoted as X11) over time with Wnt
signal dependency. Only three reactions are considered around β-catenin: the synthesis flux of
β-catenin is conserved as in the Lee model, represented by the constant rates v12 (reaction 12
in figure 4.1) as well as the β-catenin decay non-axin dependent, represented as a mass action
reaction with the rate k13 (reaction 13 in figure 4.1). The third reaction is the Axin dependent
degradation of β-catenin. As the usual object of interest, regarding Wnt pathway activity, is β-
catenin, the authors propose to add a second equation representing the complex β-catenin/TCF
(denoted as X14) to complete the model. The authors show that, taken together, the ODE for
β-catenin and the equation for β-catenin/TCF, form a simplified version of the Lee model. The
same is done to simplify the Cho model [Cho et al., 2006], resulting in the β-catenin ODE
including the Axin feedback loop.
All the models described above are deterministic and continuous models represented by
ODEs or DDEs. Their limitations include the difficulty to proceed to stochastic and discrete
simulations. Also none of the models integrate explicitly space as no volume parameter enter in
the calculation. For a complete review of the existing Wnt models, especially regarding cross-
talks and Wnt during animal development, that are not relevant for the present work, see [Kofahl
and Wolf, 2010].
4.1.3 Tymchyshyn et al. (2008)
The first stochastic model of the Wnt/β-catenin signaling pathway is proposed by [Tymchyshyn
and Kwiatkowska, 2008]. The analysis of the pathway is a support to explore the applicability
of methods from the field of concurrency programming, i.e. the stochastic pi-calculus [Pri-
ami, 1995, Priami et al., 2001], to the realm of stochastic modeling of biological systems.
The model is represented by discrete reaction rules implemented with the stochastic pi-calculus
language, and simulated using BioSPI simulation platform (www.wisdom.weizmann.ac.
il/~biospi/).
The biological system of interest is the intestinal crypt cells. The model aims to identify
the factors controlling the ability of intestinal cells to keep the balance between division and
differentiation, and to answer whether the Wnt/β-catenin pathway is one of these factors. It
is a multi-scale model combining the pathway and the cellular decision between proliferation
and differentiation processes. The representation of the cells in the intestinal crypt is abstract
in a one-dimensional space, where a cell has only an upper neighbor. The diffusion of Wnt is
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simulated by calculating its concentration at each cell position. Wnt is produced by the cells at
the bottom and transported by diffusion. The model of the intracellular pathway contains four
species that represent β-catenin, the activated receptor complex, and the active and inactive
degradation complex abstracted by Axin and phosphorylated Axin, respectively. The authors
include the negative feedback loop that produces Axin as it confers robustness toward parameter
variation. Further details of the model and its parametrization can be found in [Schaeffer, 2008].
However, discrepancies appear in parameter numerical values that occured from the parameter
conversion, i.e. the conversion from concentration to protein number does not take into account
the cell or compartment volumes.
Stochastic simulations of the model validate the hypothesis that transient activation of β-
catenin triggers cell proliferation while a prolonged signal triggers differentiation of intestinal
crypt cells. A combination of continuous deterministic and discrete stochastic model analy-
ses [Schaeffer, 2008] show oscillations of β-catenin under Wnt stimulation: at low Wnt levels
β-catenin activity presents stochastic outbreaks, whereas regular oscillations are observed with
increased stimulus. The model analysis propose that Wnt/β-catenin pathway ensures the cell
fate determination of the intestinal epithelium. These results have been validated against ex-
perimental results: mRNA Axin2 expression was quantified in HeLa cells (immortal cell line
derived from cervical cancer) after treatment for 24 hours with Wnt3a-conditioned medium.
The Axin2 expression shows oscillations with a period of 12 hours.
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4.2 Model
Subsequent to the in vitro experiments and observations (see Section 3.2), two hypotheses are
proposed regarding the dynamics of nuclear β-catenin during the early differentiation of ReN-
cell VM cells: β-catenin dynamics are influenced by (1) the ReNcell VM cells’ asynchrony
toward the cell cycle, (2) a self-induced Wnt signal that occurs during cell differentiation. By
means of computational modeling, these two hypotheses are tested through in silico experi-
ments. The model represents a population of ReNcell VM cells with the intracellular Wnt/β-
catenin pathway in each cell. To represent each of the two hypotheses, two additional reactions
are added to the intracellular Wnt pathway model.
4.2.1 The intracellular Wnt/β-catenin pathway model
A ReNcell VM cell is modeled with two compartments, the cytosol and the nucleus, that are as-
sumed to be two concentric spheres (Figure 4.2). The three main proteins, Wnt, β-catenin, and
Axin, are represented by five species. Two species represent β-catenin to illustrate its cellular
location: βcyt and βnuc, in the cytosol and in the nucleus respectively, and two species for Axin
reflecting the phosphorylation state, AxinP and Axin, both located in the cytosol. Wnt is rep-
resented by the species Wnt located extracellularly. Based on [Tymchyshyn and Kwiatkowska,
2008] (see Section 4.1.3), Axin is representing the whole degradation complex: the species
Axin and AxinP representing the inactive and active degradation complex, respectively.
The model’s reactions are presented in Table 4.1 and depicted in Figure 4.2. Axin can either
decay (r6, kA↓) or phosphorylate into AxinP (r4, kA→Ap). The latter can dephosphorylate into
Axin (r3, kAp→A), decay (r5, kAp↓), or degrade βcyt (r7, kβ⇓).
Wnt-dependent deactivation of the degradation complex is represented by Wnt promoting
AxinP dephosphorylation into Axin (r2, kAp⇒A), and thereby, indirectly increasing the amount of
βcyt (r7, kβ⇓). Only by this reaction (r2, kAp⇒A), Wnt signal influences β-catenin dynamics. If
injecting an initial amount of Wnt, the effect of the signal decreases over time, since Wnt decays
(r1, kW↓) and is not further produced.
For βcyt there exists a constant flux of production (r8, kβ↑) and decay (r9, kβ↓), in the cytosol.
Furthermore, βcyt travels between the cytosol and the nucleus, to become in the latter βnuc (r10,
kβin, and r11, kβout). βnuc produces Axin (r12, kA↑), representing the pathway negative feedback
loop. All the reactions follow mass-action kinetics (βcyt production (r8, kβ↑) is a zero order
kinetics).
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Figure 4.2: Model of the intracellular reactions of Wnt/β-catenin pathway. The two compartments cytosol
and nucleus are separated by the dashed lane. The five species are framed. For a given reaction, an arrow-less line
shows the reactant(s), and an arrow points to the product(s). Bended arrows represent protein production (flux) for
reaction 8 or protein decay (mass-action) for reactions 1, 3, 6, and 7.
4.2.2 Assumptions
The degradation complex is abstracted by only one of its component, Axin. This is possible
since Axin is the limiting factor of the degradation complex due to its low amount in com-
parison to the other three components, GSK3β, APC and CKIα [Lee et al., 2003] (see also
Section 4.1.1). The binding of Wnt molecules to the membrane receptors is not represented as
it still remains, biologically, poorly understood. Thus, the events’ cascade following the sig-
nal reception at the plasma membrane is omitted. The reaction of Wnt decay (r1) represents
its consumption and deactivation after signaling. The mechanism governing β-catenin shut-
tling between the cytosol and the nucleus remains unclear. In the model, β-catenin motion is
a facilitated diffusion as proposed in [Schmitz et al., 2011], with rate constants based on ex-
perimental data [Krieghoff et al., 2005, Krieghoff, 2006]. As suggested by the previous in vitro
experiments (see Section 3.2), the model considers that the Wnt molecules are already present
extra-cellularly, and that the passage from cell proliferation to differentiation is accompanied
cell reception of the Wnt signal. The compartment volumes, as well as the ratio between them,
are considered constant over time.
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Wnt
kW↓ÐÐ→ ∅ (1)
Wnt + AxinP kAp⇒AÐÐÐ→Wnt + Axin (2)
AxinP
kAp→AÐÐÐ→ Axin (3)
Axin
kA→ApÐÐÐ→ AxinP (4)
AxinP
kAp↓ÐÐ→ ∅ (5)
Axin
kA↓Ð→ ∅ (6)
AxinP + Bcyt kβ⇓Ð→ AxinP (7)∅ kβ↑Ð→ Bcyt (8)
Bcyt
kβ↓Ð→ ∅ (9)
Bcyt
kβinÐÐ→ Bnuc (10)
Bnuc
kβoutÐÐ→ Bcyt (11)
Bnuc
kA↑Ð→ Axin + Bnuc (12)
Table 4.1: Reactions of the intracellular Wnt/β-catenin pathway model. All reactions are following mass-
action kinetics, but β-catenin production is a constant flux. The reaction numbers correspond to the ones in the
model schema (Figure 4.2).
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4.3 Parametrization & Methods
4.3.1 Spatial parameters
Cell & Compartment volumes
The volume is a prerequisite for calculating stochastic parameters as the reaction speed is de-
pendent on the probability of molecules to collide. As the cell volume and thus the compartment
volumes might change along cell differentiation, the volume measurement is restricted to the
proliferating ReNcell VM cells, as at this stage their general shape is regular, in a cobblestone
pattern [Donato et al., 2007]. The global volume of proliferating ReNcell VM was determined
using the electric cell counter CASY® (Innovatis AG, Germany) which uses impedance tech-
nique. The ReNcell VM cells were cultivated according to the protocol previously described
in section 3.1.2. The cells were detached from the coated cell culture flask with addition of
Trypsin-Benzonase solution (2.5ml/flask) followed by trituration solution (5ml/flask) (solutions
are decribed in Section 3.1.1). As the two solutions are isotonic, they do not cause cell volume
changes. After trypsination ReNcell VM cells are in nearly spherical shape within the solution
suspension. This condition is necessary and sufficient for the device CASY® to retrieve the
mean volume of the cells analyzed in the sample. Cell suspension (25 µl) was diluted in 10 ml
of CasyTon buffer and analyzed by CASY®. The analysis results contain the mean volume of
the spherical cells passing through the capillary.
The mean of 79 cell samples, from cell passage 9 to 27, gives the average volume of ReNcell
VM cells,
VVM = 1.365 ⋅ 10+3 ± 0.0495 fl = 13.65 ⋅ 10−16 m3.
To obtain the compartment volumes, the average area of the cytosol and nucleus in prolifer-
ating cells, was measured via microscopy. The cytosol represents an average of 64% of the cell
surface, whereas the nucleus represents 26% of the cell surface. These values were considered
to hold true for the volume proportions, leading to:
Vcyto = 0.64 ⋅ 1.365 ⋅ 10+3 = 0.873 ⋅ 10+3 fl = 8.73 ⋅ 10−16 m3,
Vnucl = 0.26 ⋅ 1.365 ⋅ 10+3 = 0.355 ⋅ 10+3 fl = 3.55 ⋅ 10−16 m3.
Stochastic diffusion constants
The approach follows the one described in [Elf and Ehrenberg, 2004], i.e. the compartments are
considered to be separated containers, called sub-volumes, between which molecules diffuse in
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a discrete event manner. A diffusion event describes the motion of one particle from the center
of one compartment to the center of the other. Thereby, the cytosol and the nucleus form a
structure of two concentric spheres, the first surrounding the latter, see Figure 4.2. The rate
constants of diffusion events (diffusion constants) are determined starting off with Fick’s first
law
J = −DdΦ
dx
, (13)
that describes the diffusive flux J in [mol⋅m−2⋅min−1] through the unit area. It depends on
the diffusivity D of the diffusing species in [m2⋅s] and the concentration gradient dφ/dx in[mol⋅m−4], with the direction of the latter being against the motion. The focus is on the rate
constant of a single particle moving, such that a difference of one particle between the two
compartment centers is considered. Therefore, the gradient to dφ/dx = −1/x is set, where x is
the absolute distance between the compartment centers. Notice, that by this step, the gradient
is converted from a concentration difference over some distance with unit [mol⋅m−4] into a
difference of particle numbers over some distance with unit [m−1]. Since J is given for the
unit area, multiplication by the area A connecting the cytosol and the nucleus is needed. Under
consideration of the volume V of the compartment where the molecule starts, the stochastic
diffusion constant obtained is
Dsto = D⋅A
x⋅V , (14)
with the intended units s−1 in its final result. Notice, however, that in the following model
the time unit min is used, and not s, such that further conversions are required.
In the case of β-catenin diffusion between the two compartments, cytosol and nucleus, the
various variables of this formula are obtained as follow:
1. The diffusivity, D, can be calculated based on experiments carried out by the Fluores-
cence Recovery After Photobleaching (FRAP) technique, and is retrieved following the
formula, D = w24⋅HRT , where w is the width of the laser beam used to bleach the biological
sample, and HRT is the half-recovery time. As presented in [Krieghoff, 2006] the HRT
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of β-catenin is HRTβ = 2 ∶ 12min and the width of the laser beam used is w = 3 ⋅10−6 m.
Thus, the diffusity of β-catenin is
Dβ = (3⋅10−6)2
4⋅2.2 = 1.023 ⋅ 10−12 m2 ⋅min−1. (15)
2. The diffusion distance, x, of β-catenin between the two compartments, results from the
compartment model with two concentric spheres,
x = rnucl + rcyto − rnucl
2
. (16)
The two compartments are assumed to be spherical and their respective radius are re-
trieved from the compartment volumes mentioned in Section 4.3.1.
Following the formula for a sphere, where radius = 3√ V4⋅pi
3
, the radius of both compart-
ments are rcyto = 5.93 ⋅ 10−6 m, and rnucl = 4.39 ⋅ 10−6 m, resulting in the distance
x = 5.16 ⋅ 10−6 m.
3. The diffusion surface, A, corresponds to the surface of the nucleus. The detail of the
surface with the amount of pores on the nuclear envelop is not taken into account, as this
amount is not exactly known, and as the pore diffusion surface changes over time and in
different conditions. Thus, the nucleus surface is
Anucl = 4 ⋅ pi ⋅ r2nucl = 2.42 ⋅ 10−10 m2 (17)
4. The volume, V , from which the molecule starts to diffuse is retrieved as presented in
Section 4.3.1:
diffusion from the cytosol to the nucleus, Vcyto = 8.73 ⋅ 10−16 m3,
diffusion from the nucleus to the cytosol, Vnucl = 3.55 ⋅ 10−16 m3.
The stochastic diffusion constant for the shuttle of β-catenin from the cytosol to the nucleus
is
kβin = Dβ ⋅Anucl
x⋅Vcyto = 0.0549 min−1, (18)
and the stochastic diffusion constant for the shuttle of β-catenin from the nucleus to the cytosol
is
kβout = Dβ ⋅Anucl
x⋅Vnucl = 0.135 min−1. (19)
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4.3.2 Molecule number & Stochastic rate constants
Essential parameters of stochastic models are the initial number of molecules and stochastic
rate constants. As described in [Kuttler and Niehren, 2006], they are obtained from initial
concentrations and kinetic rate constants. In [Lee et al., 2003] concentrations are given in nM
(nmol/l), i.e. amount of molecules per volume. Thus the molecules’ number of the model
species are calculated as follow:
N = C ⋅NA ⋅ V
where C is the concentration, NA the Avogadro constant (NA ≈ 6.023 ⋅ 1023 ) and V is the
volume of the cell or compartment.
The stochastic rate constant k(0)sto of zero order reactions, i.e. reactions without reactants, is
calculated based on the volume, the Avogadro constant, and the kinetic rate constant k:
k
(0)
sto = k ⋅NA ⋅ V
For first order reactions, the kinetic and the stochastic rate constant coincide. For second
order reactions, i.e. reactions with two reactants, the stochastic rate constant k(2)sto is calculated
by:
k
(2)
sto = kNA⋅V
4.3.3 Duration and distribution of cell cycle phases
The duration of the cell cycle of ReNcell VM cells is given in [Schmöle et al., 2010] with a the
doubling time of 19.8 ± 0.6 hours. The single phase durations are retrieved according to [Alam
et al., 2004] (see Figure 2.4) that describes, in mammalian cells, a relative duration of 50% for
G1, 33.3% for S and 16.7% for G2/M of the entire duration of the cell cycle. Thus, the delay
for G2/M phase dG2= 198.4 minutes and for S phase dS= 395.6 minutes.
The amount of ReNcell VM cells committed in the cell cycle were retrieved experimentally
as described in [Mazemondet et al., 2011] and in Figure 2.5): around 20% of ReNcell VM cells
are in G2 phase and around 23% in S phase when differentiation is induced (time 0 hour).
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4.3.4 Delays
The delays are modeled by introducing for each delay d a species S and a reaction r ∶ ∅ dÐ→ S.
Initially the number of S is set to 0. Reaction r produces a single instance of S to denote the end
of the delay. Reactions that are supposed not to happen before the delay has ended are equipped
with an additional reactant and product of species S, e.g. reaction r ∶ A kBÐ→ B is transformed
to rB ∶ A + S kBÐ→ B + S. Notice that when ensuring that the number of S is always 1, the rate
of reactions with mass-action kinetics is not affected by this modification. Reaction r cannot be
directly mapped to a stochastic reaction since it is required to happen only once and at a time
point not exponentially distributed but normally distributed in time that denotes the end of delay
d. This is achieved by using the next-reaction method [Gibson and Bruck, 2000] version of the
stochastic simulation algorithm [Gillespie, 1977] that schedules the time point of each reaction
in an event queue. The firing of a reaction at a fixed time point that models the end of a delay
can thus be just scheduled as an additional event. It is assumed that the end time points of a
delay are drawn from a normal distribution on the length of the delay with a standard deviation
that is estimated to be 5% (without direct relation to the phase passage). Similar ideas have
already been presented in [Ciocchetta, 2009]. Alternatively, one can also approximate events at
normally distributed time points with sets of fast, intermediate reactions [Schlicht and Winkler,
2008].
4.3.5 Parameter estimation & Simulation
The parameter estimation for the unknown values of rate constants was done using the tool CO-
PASI [Hoops et al., 2006]. The method chosen is Hooke & Jeeves [Hooke and Jeeves, 1961],
that uses a direct search algorithm. The parameter estimation aimed to find the appropriate
parameter values in order to fit the model output to the data used for evaluation, i.e. the Lee
model or the in vitro data. The Lee model simulations were performed using the online tool JWS
Online (http://jjj.biochem.sun.ac.za/) [Olivier and Snoep, 2004]. Deterministic
simulations were also done with the tool COPASI [Hoops et al., 2006] using the determinis-
tic LSODA method. Notice that deterministic simulations does not include delays and were
only performed for the model without delays. Stochastic simulations were performed using a
small extension of the stochastic simulation algorithm, the version presented in [Gibson and
Bruck, 2000], that allows to directly reflect normally distributed delays, see Section 4.3.4. This
extension performs stochastic simulation experiments based on the modeling and simulation
framework JAMESII [Himmelspach and Uhrmacher, 2007].
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4.4 Model Evaluation
In the following section, the intracellular Wnt/β-catenin pathway model is evaluated against
the reference Lee model in order to compare the model behavior with the data used for the
parametrization. A second evaluation is done by comparing the model prediction with data that
were not used for parametrization, in this case the in vitro data obtained previously (Section 3).
4.4.1 Against the Lee model
The Lee model [Lee et al., 2003] is taken as a reference model for model evaluation as it in-
cludes model species concentration retrieved experimentally (see Section 4.1.1), as its robust-
ness has been shown [Wawra et al., 2007] (see Section 4.1.2), and as it is the main reference for
Wnt/β-catenin modeling. As the Lee model concerns a single cell with a single compartment, a
single ReNcell VM cell is modeled and simulated. The dynamics of total β-catenin in the Lee
model are compared to the dynamics of nuclear β-catenin (βnuc ) in the intracellular model, as
it is the species of interest due to its transcription role.
The initial species concentrations are taken from the Lee model, as they were retrieved from
experiments. A few reactions are conserved from the Lee model : β-catenin decay (kβ↓, r9) and
production (kβ↑, r8), and Axin decay (kA↓, r6). Table 4.2 presents the parameters’ names and
values as used in the Lee model and their respective names in the intracellular model, as well
as the conversion of the deterministic values into stochastic ones. For the remaining reactions,
kinetic rates are either taken from literature, e.g. r10, r11 (see Section 4.3.1), or estimated
(Section 4.3.5). The parameters used are displayed in Table 4.4 (set 1).
An exception forms the concentration of Wnt as, in the Lee model, it was not measured
experimentally and as Wnt signal is modeled as a transient decay. In order to compare the
dynamics of β-catenin, the same Wnt signal should be applyed to the intracellular model. In
the Lee model, Wnt signal is represented by a function of time, W(t), where 0 ≤W ≤ 1 decays
exponentially following: W (t) = exp(−0.133 ⋅ t/20). In the intracellular model, Wnt signal
is represented by a number (dimensionless) of Wnt molecules (Wnt) that decays over time
following mass action kinetics (r1). The kinetic rate value for this reaction is obtained from the
above function: kW↓ = −0.133/20 = 6.65 ⋅ 10−3 ⋅min−1.
The steady-state analysis of the intracellular model, in absence of Wnt signal, leads to the
adaptation of a few parameters that are estimated in order to fit the steady-state level proposed
in the Lee model : kβ↓ and kβ↑ were both reduced, whereas kA↓ was increased (Table 4.4 (set 1)).
Following this parameter adaptation, the steady-state of βnuc is similar to the one of total β-
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(a) No Wnt signal (b) Transient Wnt signal
Figure 4.3: Comparison of β-catenin dynamics with the Lee model . (a) In absence of Wnt signal, the con-
centration of nuclear β-catenin (βnuc ) is equivalent to the one of total β-catenin in the Lee model , ca. 25 nM.
(b) Under transient Wnt signal, the dynamics of βnuc and total β-catenin are corresponding and are quantitatively
in good agreement.
catenin in the Lee model and reaches around 25 nM (Figure 4.3a). Under transient Wnt signal,
βnuc increases in a similar way than total β-catenin, reaching a maximum increase of around
90 nM (Figure 4.3b). Small variations can be observed between the two curves, and these can
result from the differences between the two models, e.g. in the Lee model Axin production
is a flux, whereas in the intracellular Wnt model it is mass action kinetics. Nevertheless, the
intracellular model, especially βnuc, behaves in a similar manner as the reference Lee model .
4.4.2 Against the in vitro data
In a second set of experiments the intracelluar model is evaluated against the experimental data
that were not used for parametrization. For this purpose a homogeneous, i.e. synchronized,
ReNcell VM cell population is assumed, in order to verify whether this condition alone is suf-
ficient to obain, in silico, βnuc dynamics equivalent to the in vitro ones (see Figure 3.6d).
In order to fit the in vitro data, parameter values need to be adjusted (Table 4.4, set 2). This is
not surprising since the two data sets (from Lee model and our in vitro experiments) are retrieved
in different organisms, i.e. Xenopus and Human, where the enzyme activities can vary widely,
thus leading to different rate constants. However, the species initial values, in absence of Wnt
signal, remain as previously, leading to steady-state levels in the same range as the previous
ones.
The simulation data are in perfect agreement with the experimental ones for the first four time
points (Figure 4.4). After two hours of differentiation, βnuc remains constant and no second
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Figure 4.4: Model evaluation in comparison to the experimental data. Comparison of the model time course
to the experimental data for nuclear β-catenin dynamics. The simulation data fit the experimental ones for the first
time points, until 2 hours of differentiation.
increase can be observed. Thus, a homogeneous cell population in which a Wnt signal is only
induced at the beginning of the differentiation does not reproduce the experimentally observed
second increase of nuclear β-catenin .
4.4.3 Sensitivity analysis
Following the model evaluation, a sensitivity analysis of the last parameter set is performed
to determine which parameters have the most influence on βnuc dynamics. The analysis is
performed by calculating the Euclidean distance between a simulation run and the experimental
data. The results are shown in Table 4.3. For each parameter it displays the relative change
needed for the parameter value in order to obtain a change of 10% in the simulation data with a
confidence of 95%. The results show that the amount of Axin and AxinP have a high influence
on βnuc dynamics.
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Lee model Intracellular Wnt/β-catenin pathway model
Parameter Deterministic values Parameter Stochastic values
Species initial values
X11 35 nM βcyt 18390 mol.
βnuc 7483 mol.
X12 0.02 nM Axin 11 mol.
AxinP 11 mol.
W 0 ≤ W ≤ 1 Wnt 100 (dimensionless)
Rate constants
v12 0.423 nM ⋅min−1 kβ↑ 222 min−1
W(t) exp(−0.133 ⋅ t/20) kW↓ 6.65 ⋅ 10−3 min−1
k15 0.167 min−1 kAp↓ 0.167 min−1
kA↓ 0.167 min−1
k13 2.57 ⋅ 10−4 min−1 kβ↓ 2.57 ⋅ 10−4 min−1
Table 4.2: Parameters from the Lee model [Lee et al., 2003] used in the model and their stochastic conversion.
Parameters’ names and values are given as in [Lee et al., 2003]. Their corresponding names in the intracellular
Wnt model are given with their stochastic values. The stochastic values for the species initial values are given in
number of molecules (mol.).
Parameter relative change Parameter relative change
nβnuc 0.0001 kβin 0.18
nAxin 0.016 kA→Ap 0.23
nAxinP 0.018 kW↓ 0.25
kβ↑ 0.019 kAp⇒A 0.28
nWnt 0.036 kAp↓ 0.37
kβ⇓ 0.04 kβout 0.46
kAp→A 0.042 kA↑ 0.58
kA↓ 0.072 kβ↓ 0.91
nβcyt 0.098
Table 4.3: Sensitivity analysis of the model parameters. The parameter values used for this analysis are given
in Table 4.4 (set 2).
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Parameter name Deterministic values Stochastic values
Set 1 Set 2 Set 3 Set4
Species initial values
no Wnt signal
nβcyt 35 nM 18390 mol.
nβnuc 35 nM 7483 mol.
nAxin 0.02 nM 252 mol.
nAxinP 0.02 nM 219 mol.
nWnt 0 0
Species initial values
Under Wnt signal
nβcyt 24.9 nM 23.6 nM 11145 mol. 12989 mol.
nβnuc 24.9 nM 23.6 nM 4532 mol. 5282 mol.
nAxin 0.007 nM 0.051 nM 144 mol. 252 mol.
nAxinP 0.042 nM 0 nM 125 mol. 219 mol.
nWnt 100 1000 1000 1000
Rate constants
kβ↑ 0.232* 0.571* 420 600
kW↓ 6.65 ⋅ 10−3 0.27 0.6 0.27
kAp⇒A 7 10 10 20
kAp→A 0.3 0.0182 0.03
kA→Ap 3 1.619 ⋅ 10−3 0.03
kAp↓ 0.167 4.48 ⋅ 10−3
kA↓ 0.367 0.0167 2.4 ⋅ 10−3 4.48 ⋅ 10−3
kβ⇓ 4.17 ⋅ 10−4* 52.5* 3 ⋅ 10−4 2.1 ⋅ 10−4
kβ↓ 9.98 ⋅ 10−5 1.13 ⋅ 10−4 1.13 ⋅ 10−4
kβin 0.0549 0.0549
kβout 0.135 0.135
kA↑ 9.3 ⋅ 10−5 9.9 ⋅ 10−5 2 ⋅ 10−4 4 ⋅ 10−4
Table 4.4: List of model parameters. Parameters used in the different in silico experiments. Sets 1 and 2 are
used in Sections 4.4.1 and 4.4.2, respectively. Set 3 is used in Section 4.5.1, and set 4 in Sections 4.5.2 and 4.5.3.
The stochastic values for the species initial values are given in number of molecules (mol.). All rate constants are
in min−1 but the ones indicated by "*": the deterministic values of kβ↑ are given in nmol ⋅ L−1 ⋅min−1, and the
deterministic values of kβ⇓ are given in L ⋅min−1 ⋅ nmol−1.
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4.5 Results & Discussion
4.5.1 Stochastic effects
In this section, the results of a stochastic investigation exploring the effect of the low Axin
amounts, as suggested in the Lee model [Lee et al., 2003], are presented. In the Lee model,
Axin impacts β-catenin through its role in the degradation complex that corresponds in the in-
tracellular model to the impact of AxinP on β-catenin, as it represents the activated degradation
complex. This study requires a transformation of the concentrations and kinetic rate constants
in Table 4.4 (set 2), into molecule numbers and stochastic rate constants. The details of this
transformation are presented in Section 4.3.
Figures 4.5a and 4.5b show the numbers of βnuc and AxinP over time, in absence of the
Wnt signal, as the result of a single simulation run. Large fluctuations in the βnuc amount
can be observed that were not visible in the deterministic investigations presented previously
(Section 4.4.2). Along with the fluctuations, only small differences in the number of AxinP are
observed, that underline the high impact of AxinP changes on the βnuc population. This impact
results from a comparatively high rate of AxinP-dependent β-catenin degradation (kβ⇓) that is
necessary to fit the experimental data. The stochastic fluctuations contradict with the previous
in vitro results, since they do not allow for a clear transient peak of βnuc in response to the Wnt
signal.
Only two strategies to change the model parameters in order to lower stochastic fluctua-
tions while maintaining the amounts of AxinP and βnuc seem to be plausible: (i) the first is
to decrease the rate constant of AxinP-dependent β-catenin degradation (kβ⇓) and maintaining
the β-catenin level by simultaneously decreasing the flux of βcyt production (kβ↑), that would
be in accordance with the sensitivity analysis results (see Section 4.4.3). However, already
small modification of this kind has a high impact on βnuc dynamics and prevents βnuc from
increasing in response to Wnt signal (results not shown). (ii) The second strategy is to deploy
the inertia of β-catenin reacting on AxinP number changes. Since the number of β-catenin is
relatively high, observable changes due to differences in AxinP number can only take place
with a certain delay. The quantity of AxinP is impacted only by its decay (kAp↓) and its de-
/phosphorylation (kAp→A, kA→Ap). Instead of increasing one of the corresponding rate constants
separately, which would result in a change in the overall amount of AxinP, one can increase the
rate constants for de-/phosphorylation simultaneously. Figures 4.5c and 4.5d show the results
when increasing the rate constants for dephosphorylation (kAp→A) by about 1000 times and the
one for phosphorylation (kA→Ap) accordingly. Changes in AxinP numbers happen much faster.
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However, although they are lower, the stochastic fluctuations in the βnuc dynamics are still too
high. Raising the dephosphorylation rate (kAp→A) even more seems not plausible biologically,
since then changes on the few AxinP molecules happen in periods of milliseconds.
Therefore, it is convincing that in the intracellular Wnt pathway model, with low AxinP level
as derived from [Lee et al., 2003], stochastic fluctuations in the βnuc level cannot be limited to
fit the experimental data. This indicates that either ReNcell VM cells contain higher level of
Axin than suggested for the Xenopus oocyte by [Lee et al., 2003] or that the pathway model,
and thus the understanding of the system, may miss an important mechanism to reduce stochas-
tic noise, such as dimerization [Bundschuh, 2003, Morishita, 2004] or an additional negative
feedback loop [Orrell et al., 2006].
Additional parameter fitting experiments are performed, thereby stepwise increasing the
amount of AxinP and Axin. It results in a parameter set with acceptable stochastic fluctua-
tions at an initial amount of AxinP of 125, when starting experiments in presence of Wnt signal,
see Table 4.4 (set 3). In Figure 4.6a, the dynamics of βnuc over time for 10 simulation runs are
shown, where the Wnt signal is switched off. One can see that the fluctuations in βnuc levels
have been effectively decreased. The t-test provides that at the time point of maximum devia-
tion around 7 hours (ca. 426 minutes), the mean value of βnuc numbers in the 10 simulation
runs lies in the interval of 254.13 (ca. 5.5% of the simulated mean value) around the simulated
mean value with a confidence of 95%. Figure 4.6b shows the dynamics of βnuc over time for 10
simulation runs, when the Wnt signal is on. The simulation data show a transient peak within
the standard deviation of the experimental data.
4.5.2 Impact of the cell cycle on β-catenin dynamics
In this section, the impact of the cell cycle on the overall amount of β-catenin in ReNcell
VM cell populations is investigated. Therefore, heterogeneous cell populations are considered
with an individual cell cycle state assigned to each cell. The detailed processes of the cell cycle
are not reflected, only its impact on the Wnt/β-catenin pathway is taken into account. Also,
as the M phase is really fast (less than an hour) and not represented in the data available (see
Figure 2.5), the phase G2 abstracts both G2 and M phases.
The cell cycle is modeled as a delay on the start time of Wnt degradation (kW↓) and Wnt-
dependent Axin dephosphorylation (kAp⇒A). That is the corresponding reactions r1 and r2 are
ensured not to happen before a fixed time point has passed. This time point is drawn from a
normal distribution on the length of the delay with a standard deviation that we assume to be
5%. Cells that are already in the G1 phase at the beginning of a simulation experiment, i.e. at
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Figure 4.5: Effects of AxinP on nuclear β-catenin dynamics according stochastic simulation. In absence of
Wnt signal, small variations of AxinP (a) impact βnuc dynamics (b) leading to high variance. The parameter values
used for these simulations are converted from the Table 4.4 (set 2). Increase of kAp→A and kA→Ap by 1000 accelerate
AxinP changes (c) but βnuc fluctuations still remain too high (d).
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(a) No Wnt signal (b) Transient Wnt signal
Figure 4.6: Nuclear β-catenin dynamics with higher number of AxinP. Stochastic simulation of βnuc in ab-
sence of Wnt signal (a), and under transient Wnt signal (b). The parameter values used for these simulations are in
Table 4.4 (set 3).
time 0 hour, start to perform their reactions without any delay. The integration of delays into
the model is presented in Section 4.3.4.
Cell cycle states, i.e. G1, S, and G2, are assigned following the distribution of cells over
the cycle phases as shown in Figure 2.5 and Section 4.3.4. For example in a population of n
cells, 0.23∗n cells are assigned to state S. Potential rounding problems are solved by randomly
assigning states to remaining cells with probabilities to be in certain states again following the
experimental data.
The delay for each cell is computed in the following way: cells are assumed to be equally
distributed over their respective states. That is, to a cell in state G2 a delay t = κ ∗ dG2 is
assigned, where κ is equally distributed in [0,1] and dG2 is the duration of phase G2. Similarly,
since each cell in state S has to additionally pass state G2, the delay of a cell in state S is given
by t′ = dG2 + κ ∗ dS , with dG2 being the duration of phase G2.
In Figure 4.7a the relative amount of nuclear β-catenin (βnuc ) for a single simulation run
with 100 cells is presented, based on the parameters given in Table 4.4 (set 3). The simulation
data presented are calculated in the same manner as the Western-blot data (see Section 3.1.6).
Briefly, the sum of βnuc amounts for the 100 cells for each time points. The resulting values
are normalized to the one at time point 0 hour, that is set to 1. Similar to the results presented
in the previous section, a single transient increase is observed. This peak is however lower than
expected. The maximum β-catenin increase as obtained from the experiments (Figure 3.6d,
Section 3.2.1) is 1.48 at 1 hour. However, the peak in Figure 4.7a is about 1.28 at 36 minutes,
i.e. only 86% of the expected amount is reached. The reason can be seen in Figure 4.7b, where
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(a) Cell population analyses (b) Single cell analyses
Figure 4.7: Dynamics of nuclear β-catenin in heterogeneous cell population. Population of 100 cells is simu-
lated and compared to the experimental data. (a) The total cell population is analyzed, the simulation data do not
correlate with the experimental ones. (b) Single cell analysis shows the delay in β-catenin dynamics due to the cell
cycle asynchrony. Parameters used are given in Table 4.4 (Set 3).
βnuc dynamics are shown for the 100 cells, separately. The β-catenin amounts in most of the
cells initially dedicated to the cell cycle, start to increase not before 30 minutes, i.e. after the
time of the first peak is over. Thus, only about 60% of the cells contribute to the first peak,
resulting in the limited increase. This shows that when modeling the Wnt/β-catenin pathway in
ReNcell VM cells the cells’ commitment to the cell cycle should be considered.
Further parameter fitting experiments are performed and Table 4.4 (set 4) shows the obtained
parameter set. Only a few parameters are adjusted compared to the previous parameter set. Fig-
ure 4.8a shows the corresponding simulation results. It can be seen that with the new parameter
set, the first increase of nuclear β-catenin is well-fitted.
The simulation results presented in Figure 4.8a indicate that when studying the Wnt path-
way in ReNcell VM cells by wet-lab experiments the impact of the cell cycle on the β-
catenin amount can be neglected. The reason for this becomes obvious when looking at the
dynamics of β-catenin for each cell separately, as presented in Figure 4.7b. Although, all the
cells that are initially dedicated to the cell cycle start their β-catenin increase comparatively late,
they do not perform it simultaneously but rather widely distributed over time (between 0.5 and
10 hours). Thus, summing up over all cells the individual peaks only lead to small deviations. It
is important to notice here that this observation is rather independent from the particular design
decisions of the model but most directly results from the distribution of ReNcell VM cells over
the cell cycle as it is obtained experimentally (see Figure 2.5) and the basic knowledge about
the Wnt/β-catenin pathway as represented in the model.
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4.5.3 Self-induced Wnt signaling
To model self-induced Wnt signaling, the intracellular Wnt/β-catenin pathway model is ex-
tended with a single reaction representing both Wnt production and secretion in a rather abstract
way. This reaction occurs with a given delay after cells exit the cell cycle. The delay is to reflect
the time necessary to induce the signal. It is implemented in the same way as the one for the cell
cycle reaction (details in Section 4.3.4). The time delay is selected in a broad range of values,
since it encompasses various biological processes, i.e. gene transcription of Wnt molecules,
their subsequent intracellular trafficking, post-translational modifications [Coudreuse and Ko-
rswagen, 2007, Lorenowicz and Korswagen, 2009], secretion of Wnt in the extracellular envi-
ronment, and their binding to the cell receptors, Fz, and LRP6 (see Figure 2.1).
Two ways of self-induction are tested: a discrete and a continuous Wnt signal. For the
discrete signal, once the delay is over, each cell produces 1000 Wnt for itself, i.e. autocrine
signaling. For the continuous one, also after the time delay, each cell continuously produces,
for itself, Wnt molecules with rate constant kW↑ = 0.05 min−1. Simulation experiments are
performed with a cell population of 100 cells. Delays selected for the signal induction are 450
and 150 minutes for the discrete and continuous signal, respectively. In Figures 4.8b and 4.8c
the results of a single simulation run are presented. The first peak (0 to 2 hours) of βnuc is
still fitting the experimental data, in both cases. However, the simulation data of the continuous
signal is the only one to fit all the other experimental time points, i.e. 3, 4, 8, and 12 hours.
These results suggest that continuous and autocrine Wnt signaling occurs in ReNcell
VM cells during the early differentiation, from 2.5 to 8, and potentially at the beginning of
the late differentiation, i.e. 12 hours.
However, the in vitro data feature a substantial standard error at the time points 4 and 12
hours. That is, a plateau between 2 and 4 hours is plausible followed by the second increase
around 8 hours. Although the simulation data for the discrete signal do not fit exactly the
experimental ones, this hypothesis can not be excluded.
The model abstraction does not distinguish between Wnt production and secretion, it re-
mains, nevertheless, essential to know which mechanism is involved, in order to understand the
pathway functioning. Production of Wnt molecules has been investigated in ReNcell VM cell at
3, 6, and 24 hours of differentiation [Hübner, 2010,Mazemondet et al., 2011]. Only for the latter
time point an increase of Wnt mRNA level (Wnt5a and Wnt7a) has been observed, leading to
the conclusion that Wnt production does not occur during the early differentiation of ReNcell
VM cells. However, due to the only few time points investigated this conclusion is questionable
and will need further experimental analyses to be verified.
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Nevertheless, supposing that Wnt production is performed before differentiation starts, the
continuous and autocrine Wnt signal hypothesis can still hold true when considering continu-
ous Wnt molecule secretion. An alternative mechanism for Wnt signaling in ReNcell VM cells
can arise from Wnt molecule production prior to differentiation, that are subsequently stored in
cytosolic vesicles (see Figure 2.1). The vesicles can fuse continuously with the membrane in or-
der to release Wnt molecules outside of the cell inducing signaling [Coudreuse and Korswagen,
2007]. In order to be validated, continuous Wnt secretion can be tested in vitro: a continuous
inhibition of the Wnt/β-catenin pathway, e.g. inhibition with Dickkopf 1, Mesd (both inhibitors
of Wnt receptors), or Porcupin [Semënov et al., 2001, Lu et al., 2010, Coudreuse and Kor-
swagen, 2007], followed by kinetic analysis of nuclear β-catenin between 4 and 12 hours of
differentiation, could be performed.
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(a) Cell cycle (b) Discrete autocrine Wnt signal
(c) Continuous autocrine Wnt signal
Figure 4.8: Simulation results for the time-course of nuclear β-catenin (βnuc). Population of 100 cells is
simulated and simulation data are compared to the experimental data. (a) The cell population asynchrony toward
the cell cycle does not give rise to a second increase of nuclear β-catenin after 2 hours. In addition to the cell
cycle asynchrony, a self-induced Wnt signal is added. A discrete and autocrine Wnt signal (b) does not fit all
the experimental time points, whereas a continuous and autocrine Wnt signal (c) gives simulation data is perfect
agreement to the experimental ones. Parameters used for these experiments are given in Table 4.4 (Set 4). The
simulation data presented are calculated in the same manner as the Western-blot data (see Section 3.1.6). Briefly,
the sum of βnuc amounts for the 100 cells for each time points. The resulting values are normalized to the one at
time point 0 hour, that is set to 1.
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Chapter 5
Conclusions and Future Work
In this dissertation, computational systems biology is employed to elucidate the dynamics of
Wnt/β-catenin in ReNcell VM cell differentiation. The work encompasses both wet-lab ex-
periments and computational modeling that results in two findings: signaling proteins of the
Wnt/β-catenin pathway present a biphasic kinetic regulation, and the asynchrony of ReNcell
VM cells during differentiation does not impair the in vitro observations.
Quantitative Western-blot analyses show that the signaling proteins, i.e. LRP6, Dvl2, and
β-catenin, are highly regulated during the early differentiation, i.e. 0 to 3 hours, and the late
differentiation, i.e. after 24 hours, of ReNcell VM cells. These results underline the importance
of Wnt/β-catenin pathway during ReNcell VM cell differentiation. Furthermore, it illustrates
the need to investigate protein dynamics over time and space, as in various subcellular locations
protein are differently regulated, e.g. β-catenin in the nucleus and in the cytosol. These results
are a first step toward understanding the role of the Wnt/β-catenin signaling pathway in hNPC
differentiation into neurons.
A stochastic computational model of ReNcell VM cell population is built to evaluate the
sources of the biphasic kinetic, especially regarding nuclear β-catenin. Simulation data show
that the cell asynchrony during differentiation does not impair the observations made previously
in vitro. Furthermore, a continuous and autocrine Wnt signal is proposed as a mechanism
responsible for the second phase of nuclear β-catenin accumulation,that would need to be
validated by performing further wet-lab experiments. Furthermore, stochastic analyses of
the model reveal discrepancies with deterministic ones, that provide insights regarding the
Wnt/β-catenin pathway in ReNcell VM cell population.
Molecular biologists commonly explore signaling pathways by influencing their behavior
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under external inhibition or activation, e.g. inhibition of GSK3β to activate Wnt/β-catenin path-
way [Schmöle et al., 2010]. Although widely and successfully used, these manipulations result
in a truncated picture of the system and need to be supported by physiological experiments, i.e.
without external influence. The present work illustrates such dual investigation, and shows that
activation of the pathway with addition of Wnt3a leads to phenomena not observable in phys-
iological condition, e.g. the phosphorylation-dependent Dvl2 mobility shift. Both approaches,
physiological and manipulated explorations, done in synergy, are needed to fully understand
biological systems.
Kinetic studies are challenging due, on the one hand to the time scale of molecular events
(from nanosecond to hour), and on the other hand to technical limitations and manpower skills.
Determining the relevant time points to study the behavior of signaling pathway during cellular
process remains challenging, and necessitates a clear definition of the processes to be observed,
e.g. to follow protein phosphorylation, kinetic analyses in a time frame of second are needed.
Western-blot technique has been used over the past thirty years [Towbin et al., 1979,Burnette,
1981]. Its simplicity combined to its large field of application are making it a broadly used
technique in biology. Since quantitative Western-blotting is available [Wang et al., 2007] and in
constant improvement [Kiyatkin and Aksamitiene, 2009], the data issued from this technique
are used in the context of computational systems biology. However, as these data are issued
from cell population analyses, their use for modeling is less favored than data issued from single
cell analysis [Anselmetti, 2009, pg.VI]. These two different approaches and investigations of
biological systems are complementary and should be performed in a synergistic manner in order
to provide a complete picture of the systems. As presented in this work, the use of Western-
blot data for modeling purposes is still valuable and allows exploration of the diversity in cell
populations that needs to be taken into account when performing wet-lab experiments.
In order to close the loop of the computational systems biology workflow, a couple of wet-
lab experiments can be performed to in-/validate the predictions obtained from in silico exper-
iments. As Western-blot technique failed to detect Axin in ReNcell VM cells, other methods
such as immunostaining and microscopy could be used. Alternatively, immunoprecipitation and
concentration of cell lysates before Western-blotting, could succeed to quantify Axin amounts.
By doing so, answer about the source of stochastic fluctuations in the intracellular Wnt pathway
model, could be retrieved. So far, chemical synchronization of ReNcell VM cells is too armful
to be followed by further experiments. However, using other techniques such as flow cytometry
could circumvent chemical synchronization. Flow cytometry can be used to sort the cells de-
pending on their cell cycle phases. By this way, cells in G1 phase could be selected and cultured
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to perform differentiation experiments with synchronized cells. However, as ReNcell VM cells,
like other stem and progenitor cells, are delicate to handle and might suffer from such manipu-
lation. In order to confirm that the second increase of nuclear β-catenin is due to self-induced
Wnt signal, in vitro experiments should be performed. As proposed in Section 4.5.3, constant
inhibition of the pathway, e.g. in presence of exogenous proteins like Dickkopf 1, Mesd, or
Porcupin [Semënov et al., 2001,Lu et al., 2010,Coudreuse and Korswagen, 2007], followed by
kinetic analyses at time points between 8 and 12 hours, would provide data to compare to the
simulation ones.
The lack of quantitative and reliable data remains the major bottleneck for the modeling of
dynamic systems. Gathering parameter values from different sources is a tedious task that might
lead to discrepancies in the model behavior, and necessitates particular attention if conversion
between deterministic and stochastic values are needed [Mazemondet et al., 2009]. Although
parameter estimation aims to overcome this deficiency, it is not a perfect solution as it might
lead to another problem: the over-fitting of the simulation data to the experimental ones. Various
data sets might result in data fitting during the model evaluation, but produce different model
predictions.
Model reuse is another challenge in computational systems biology [Uhrmacher et al., 2005].
The model presented in this dissertation can easily be reused and extended as it is expressed in
terms of chemical reactions. Among possible extension, analyze of the Wnt/β-catenin pathway
impact on neighbor cells can be performed by assigning position to each cell. This would allow
in silico investigation of paracrine Wnt signal, as well as Wnt gradient in the cell field, and give
insights into the mechanisms of Wnt morphogens in the cell-cell communication.
In order to make modeling task accessible to biologists, the development of modeling lan-
guages that support modeling with chemical reactions is needed. Efforts in this direction already
started than need to be continued, e.g. κ-calculus [Danos and Laneve, 2004,Krivine et al., 2009],
Bionetgen [Faeder et al., 2005], or React(C) [John et al., 2011]. There is also a need for these
languages to be expressive in order to support delays that are an important feature of biological
systems, e.g. delay for transcription process. First efforts are made is this direction [Caravagna
and Hillston, 2010] but most of the languages for stochastic modeling do not support reaction
delays. A clear framework for modeling development that answers biologist needs and ex-
pectations, and not computer scientists needs, is needed so that computational modeling can
be established as one of the routine tool for biologists and experimentalists. This emphasizes,
once more, the challenge for communication and understanding between scientists from various
fields involved in the process of computational systems biology, and also its difficulty.
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Glossary
Autocrine signaling Type of cell signaling in which a cell secretes signal molecules
that act on itself or on other adjacent cells of the same type
[Alberts et al., 2002].
Differentiation Process by which a cell undergoes a change to an overtly spe-
cialized cell type [Alberts et al., 2002].
Endoplasmic Reticulum Labyrinthine membrane-bounded compartment in the cyto-
plasm of eucaryotic cells, where lipids are synthesized and
membrane-bound proteins and secretory proteins are made
[Alberts et al., 2002].
Growth factors Extracellular polypeptide signal molecule that can stimulate a
cell to grow or proliferate, such as epidermial growth factor
(EGF) [Alberts et al., 2002].
Half-life Time required for half the quantity of a substance deposited in
a living organism to be eliminated.
Half-recovery time Time required for a bleach area to recover half of its initial
intensity.
Protein kinase Enzyme that transfers the terminal phosphate group of ATP to
a specific amino acid of a target protein [Alberts et al., 2002].
Mass-action kinetics Define chemical reaction rates as a product of a rate constant
and the concentrations of the reactants [Aldridge et al., 2006].
Morphogen Signal molecule that can impose a pattern on a field of cells
by causing cells in different places to adopt different fates [Al-
berts et al., 2002].
Negative feedback loop Counteracts the effect of a stimulus and abbreviates and limits
the level of the response, making the system less sensitive to
perturbations [Alberts et al., 2002].
Ordinary differential equations
(ODEs)
Describe functions of one independent variable (e.g. time t)
[Klipp et al., 2005].
Phosphorylation Reaction to which a phosphate group becomes covalently cou-
pled to another molecule [Alberts et al., 2002].
Proliferation Process of cell growth and division.
Restriction point Commitment point during the cell cycle.
82
Robustness Ability to maintain biological function despite external vari-
ation, internal fluctuations, or failure of system parts [Klipp
et al., 2005].
Transcription Copying of one strand of DNA into a complementary RNA se-
quence by the enzyme RNA polymerase [Alberts et al., 2002].
Translation Process by which the sequence of nucleotides in a messenger
RNA molecule directs the incorporation of amino acids into
protein [Alberts et al., 2002].
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Thesis Statements
1. Understanding the mechanisms of human neural progenitor cells (hNPCS) differentiation
into neurons is fundamental to develop replacement therapies in the context of neurode-
generative diseases, e.g. Parkinson’s disease.
2. ReNcell VM cells are stable hNPCs that can be cultured in vitro and allow experimental
investigation of the molecular mechanisms involved in neuron differentiation. However,
like stem and progenitor cells, they are too sensitive for certain experiments, e.g. syn-
chronization.
3. The Wnt/β-catenin signaling pathway plays an important role in the differentiation of
hNPCs. Its activation is characterized by spatio-temporal changes of signaling proteins,
especially accumulation of β-catenin in subcellular compartments.
4. Western-blot experiments on ReNcell VM cells reveal biphasic kinetics of signaling pro-
teins in general and of β-catenin in particular.
5. Computational systems biology integrates wet- and dry-lab techniques and experiments
to explore complex and dynamic biological systems in an integrative manner. Thus, such
approach is suitable to explore the possible sources of the biphasic kinetics observed in
ReNcell VM cells.
6. Dynamic and stochastic models are suitable to investigate signaling pathways. Their
development requires information collection about the pathway structure and kinetic pa-
rameters. Those can be retrieved from literature and wet-lab data. However, integrating
these diverse types of information in stochastic models deserves particular attention.
7. Model development is followed by its evaluation, i.e. the simulation data are compared to
a reference model data or to experimental data, in order to assure that a model can repro-
duce expected behavior patterns. The influence of parameters onto the model behavior is
inquired with sensitivity analysis. This revealed the high influence of the species (Axin)
in the model of Wnt/β-catenin in ReNcell VM cells.
8. Applying different approaches for model analysis reveal that stochastic simulation is cen-
tral to exhibit problems that occur when adopting parameter values issued from determin-
istic models. For the Wnt/β-catenin model in ReNcell VM cells these problems might
lie in the model structure or might be due to the low amount of one component (Axin).
Increasing the latter seems suitable in the context of ReNcell VM cells.
9. The heterogeneity of ReNcell VM cell populations has to be taken into account when
analyzing Wnt/β-catenin model. Integrating the cell asynchrony necessitates adaptation
of model parameters in order to fit the simulation to the wet-lab data. However, the cell
asynchrony does not affect significantly the general pattern of β-catenin dynamics and is
not the source of the second phase observed in the kinetic analyses.
10. A self-induced Wnt signal within ReNcell VM cell population can reproduce the second
increase of β-catenin dynamics. In order to confirm whether this signal is subsequent
to continuous Wnt secretion, wet-lab experiments in presence of Wnt/β-catenin pathway
inhibitor, e.g. Dickkopf 1 or Porcupin, should be performed.
